• Home
  • About Us
  • Health Insurance Companies

Health Plan News

Timely Health Plan News and Commmentary.

Health Plan News
Home Archives for Medical And Healthcare

HearUSA Reports Second Quarter 2010 Results

Posted on August 10, 2010 Written by Annalyn Frame

SOURCE: HearUSA

WEST PALM BEACH, FL–(Marketwire – August 10, 2010) – HearUSA, Inc. (NYSE Amex: EAR), a
leader among the nation’s hearing care providers, reported financial
results for the second quarter ended June 26, 2010.

Financial Results for Second Quarter 2010

In the second quarter of 2010, net revenues increased 9% to $21.4 million
from $19.6 million in the previous quarter, but decreased 6% from $22.7
million in the second quarter of 2009. The decrease year-over-year was
principally the result of some insurance plans eliminating, changing or
limiting their hearing care benefits at the beginning of 2010. The company
implemented a number of plans and strategies during the first quarter of
2010 which helped to replace most of the lost insurance business, including
increased marketing to its existing insurance base and private pay
customers. The company also increased the marketing of its AARP Hearing
Care Program and made it available to AARP members in 45 states through all
177 HearUSA centers and a network of independent AARP Hearing Care Program
providers. These combined efforts were the primary cause of the 9% increase
in second quarter revenue over the previous quarter.

The loss from continuing operations totaled $1.9 million in the second
quarter of 2010, compared to a loss of $2.5 million in the previous
quarter, and income of $963,000 in the second quarter of 2009. The loss
from continuing operations includes AARP advertising costs of $957,000
incurred in the second quarter of 2010 compared to $253,000 in the previous
quarter and none incurred in the second quarter of 2009. Advertising,
royalties and administrative costs associated with the AARP program totaled
$1.3 million in the second quarter of 2010, $588,000 in the previous
quarter and $142,000 in the second quarter of 2009.

Net loss attributable to common stockholders was $2.2 million or $(0.05)
per basic and diluted share in the second quarter of 2010, as compared to a
net loss of $2.7 million or $(0.06) per basic and diluted share in the
previous quarter of 2010, and net income of $1.1 million, or $0.03 per
basic and $0.02 per diluted share, in the same year-ago period. Net loss
attributable to common shareholders in the second quarter of 2009 included
income from discontinued operations of $336,000 or $0.01 per basic and
diluted share.

Management Commentary

“Our focus during the second quarter of 2010 was to increase revenues to
offset the loss of the managed care business in the first quarter and to
expand the reach of the AARP program,” said Stephen Hansbrough, CEO and
chairman of HearUSA. “The 9% increase in revenues over the first quarter of
2010 and the successful launch of the AARP program to AARP members in a
total of 45 states has given us a strong base for continued success going
into the third quarter.

“We have seen appointments grow at an accelerating pace since we launched
our AARP national advertising campaign, and AARP included the HearUSA
program in its publications and web sites in the latter half of the second
quarter. We expect this momentum to continue and believe that center
revenues will grow between 9% and 15% in the second half of 2010 when
compared to the first half, and our target is to grow center revenues 15%
to 20% in 2011 when compared to 2010.

“We will focus primarily on expanding the number of independent providers
participating in the AARP network during the rest of 2010 and expect to
have more than 800 participating providers by the end of the year,”
continued Mr. Hansbrough. “Both HearUSA and AARP will also continue to
increase awareness and member communications during the remainder of the
year. We believe that it will take time to fully develop the provider
network and educate the AARP membership base. Our targets for 2011 are to
expand the AARP network to more than 2,000 participating providers and
generate AARP network sales of over 30,000 units.”

Conference Call

HearUSA will hold a conference call at 4:30 p.m. Eastern time, August 10,
2010, to discuss its second quarter 2010 financial results. The company’s
senior management will host the presentation, which will be followed by a
question and answer period.

To participate in the call, dial the appropriate number 5-10 minutes prior
to the start time, request the HearUSA conference call and provide the
conference ID: 7HEARUSA.

Date: Tuesday, August 10, 2010
Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)
Domestic callers: 1-800-862-9098
International callers: 1-785-424-1051
Conference ID#: 7HEARUSA

A Web simulcast and replay will be available via the investor relations
section of the company’s website at www.hearusa.com.

If you have any difficulty connecting with the conference call or webcast,
please contact the Liolios Group at 1-949-574-3860.

A telephone replay of the call will be available later that evening and
will be accessible until August 17, 2010:

Toll-free replay number: 1-877-870-5176
International replay number: 1-858-384-5517
Replay Pin Number: 11721

About HearUSA

HearUSA is the recognized leader in hearing care for the nation’s top
managed care organizations through its 177 company-owned centers and
network of more than 2,000 hearing care providers. HearUSA is the nation’s
only hearing care provider accredited by URAC, an independent, nonprofit
health care accrediting organization dedicated to promoting health care
quality through accreditation, certification and commendation. HearUSA is
also the administrator of the AARP Hearing Care Program, designed to help
millions of Americans aged 50+ who have untreated hearing loss. For more
information about HearUSA visit www.hearusa.com, or go to
www.hearingshop.com for a wide selection of hearing related products
available for purchase online.

Forward Looking Statements

This press release contains forward-looking statements within the meaning
of the Securities Litigation Reform Act of 1995, including those statements
that HearUSA plans to expand its AARP program to include more than 800
participating independent hearing care providers during the course of 2010
and over 2,000 participating providers in 2011; that the company expects
second quarter 2010 momentum to continue; that the company believes that
center revenues will grow between 9% and 15% in the second half of 2010
when compared to the first half of 2010; that the company’s target is to
grow revenues 15% to 20% in 2011 when compared to 2010; and that the
company plans to generate AARP network sales of over 30,000 units. These
statements involve certain risks and uncertainties that could cause actual
results to differ materially from those in the forward-looking statements.
Potential risks and uncertainties include such factors as the company’s
continuing ability to replace lost and decreased revenue from insurance
contracts with increased self-pay revenue, replacement insurance agreements
and other revenue; the company’s ability to attract and retain a sufficient
number of independent providers in all 50 states to participate in the AARP
program; the company’s ability to successfully integrate the AARP program
into its company-owned centers; the ability of the Company to capitalize on
the advertising efforts for the AARP program; the company’s ability to
control costs; the company’s ability to generate sufficient cash flows to
fund its various advertising campaigns; the ability of the company to
maintain unit sales of Siemens hearing aids; market demand for the
company’s goods and services; changes in the pricing environment; general
economic conditions in those geographic regions where the company’s centers
are located; consumer confidence in the general economy; the impact of
competitive products; and other risks and uncertainties described in the
company’s filings with the Securities and Exchange Commission, including
the company’s Form 10-K for the fiscal year ended December 26, 2009.



                               HearUSA, Inc.
                  Consolidated Statements of Operations
            Three Months Ended June 26, 2010 and June 27, 2009
                                (unaudited)


                                                 June 26,       June 27,
                                                   2010           2009
                                               ------------   ------------
                                                 (Dollars in thousands,
                                                except per share amounts)

Net revenues
Hearing aids and other products                $     19,796   $     20,653
Services                                              1,613          2,014
                                               ------------   ------------
Total net revenues                                   21,409         22,667
                                               ------------   ------------

Operating costs and expenses
Hearing aids and other products                       5,290          5,072
Services                                                412            388
                                               ------------   ------------
Total cost of products sold and services
 excluding depreciation and amortization              5,702          5,460

Center operating expenses                            12,209         10,908
General and administrative expenses                   3,769          3,661
Depreciation and amortization                           564            588
                                               ------------   ------------
Total operating costs and expenses                   22,244         20,617
                                               ------------   ------------
Income (loss) from operations                          (835)         2,050
Non-operating income (expenses)
Gain (loss) on foreign exchange                          (5)           375
Interest income                                           5              -
Interest expense                                       (841)        (1,252)
                                               ------------   ------------
Income (loss) from continuing operations
 before income tax expense                           (1,676)         1,173
Income tax expense                                     (220)          (210)
                                               ------------   ------------
Income (loss) from continuing operations             (1,896)           963
Discontinued operations attributable to
 HearUSA, Inc.
Income from discontinued operations, net of
 income tax benefit of $270 in 2009                       -            250
Gain on sale of discontinued operations                   -          1,632
Income tax expense on sale of discontinued
 operations                                               -         (1,546)
                                               ------------   ------------
Income from discontinued operations                       -            336
                                               ------------   ------------
Net income (loss)                                    (1,896)         1,299

Net income attributable to noncontrolling
 interest                                              (238)          (131)
                                               ------------   ------------
Net income (loss) attributable to HearUSA,
 Inc.                                                (2,134)         1,168
Dividends on preferred stock                            (32)           (35)
                                               ------------   ------------

Net Income (loss) attributable to HearUSA,
 Inc. common stockholders                      $     (2,166)  $      1,133
                                               ============   ============

Loss from continuing operations attributable
 to HearUSA, Inc. common stockholders per
 common share - basic                          $      (0.05)  $       0.02
                                               ============   ============
Loss from continuing operations attributable
 to HearUSA, Inc. common stockholders per
 common share - diluted                        $      (0.05)  $       0.02
                                               ============   ============

Net loss attributable to HearUSA, Inc. common
 stockholders per common share - basic         $      (0.05)  $       0.03
                                               ============   ============
Net loss attributable to HearUSA, Inc. common
 stockholders per common share - diluted       $      (0.05)  $       0.02
                                               ============   ============

Weighted average number of shares of common
 stock outstanding - basic                           44,922         44,837
                                               ============   ============

Weighted average number of shares of common
 stock outstanding - diluted                         44,922         45,340
                                               ============   ============

Amounts attributable to HearUSA, Inc. common
 stockholders:

Income (loss) from continuing operations, net
 of tax                                        $     (2,134)  $        832
Discontinued operations, net of tax                       -            336
                                               ============   ============

Net income (loss) attributable to HearUSA,
 Inc. common stockholders                      $     (2,134)  $      1,168
                                               ============   ============





                               HearUSA, Inc.
                        Consolidated Balance Sheets
                                (unaudited)


                                                 June 26,     December 26,
ASSETS                                             2010           2009
                                               ------------   ------------
                                                 (Dollars in thousands,
                                                except per share amounts)
Current assets
Cash and cash equivalents                      $      4,026   $      7,037
Short-term marketable securities                      1,306          4,106
Accounts and notes receivable, less allowance
 for doubtful accounts of $677 and $616               5,506          5,554
Inventories                                           1,409          1,844
Prepaid expenses and other                              417            464
                                               ------------   ------------
Total current assets                                 12,664         19,005
Property and equipment, net                           3,463          4,021
Goodwill                                             51,928         51,495
Intangible assets, net                               12,529         12,816
Deposits and other                                      698            731
Restricted cash and cash equivalents                  3,252          3,245
                                               ------------   ------------
Total Assets                                   $     84,534   $     91,313
                                               ============   ============

LIABILITIES AND STOCKHOLDERS'  EQUITY
Current liabilities
Accounts payable                               $      9,458   $      7,070
Accrued expenses                                      1,907          2,253
Accrued salaries and other compensation               3,224          3,520
Current maturities of long-term debt                  5,357          5,983
Income taxes payable                                      -          1,974
Dividends payable                                        35             35
                                               ------------   ------------
Total current liabilities                            19,981         20,835
                                               ------------   ------------
Long-term debt                                       33,781         36,139
Deferred income taxes                                 7,775          7,335
                                               ------------   ------------
Total long-term liabilities                          41,556         43,474
                                               ------------   ------------
Commitments and contingencies
                                               ------------   ------------

Stockholders' equity
Preferred stock (aggregate liquidation
 preference $2,330, $1 par, 7,500,000 shares
 authorized)
Series H Junior Participating
 (none outstanding)                                       -              -
Series J (233 shares outstanding)                         -              -
                                               ------------   ------------
Total preferred stock                                     -              -

Common stock: $.10 par; 75,000,000 shares
 authorized 45,451,160 and 45,381,750 shares
 issued                                               4,545          4,538
Additional paid-in capital                          138,359        137,863
Accumulated deficit                                (119,804)      (114,982)
Treasury stock, at cost: 523,662 common shares       (2,485)        (2,485)
                                               ------------   ------------
Total HearUSA, Inc. Stockholders' Equity             20,615         24,934

Noncontrolling interest                               2,382          2,070
                                               ------------   ------------
Total Stockholders' equity                           22,997         27,004
                                               ------------   ------------
Total Liabilities and Stockholders' Equity     $     84,534   $     91,313
                                               ============   ============

Company Contact:
HearUSA, Inc.
Stephen J. Hansbrough
Chairman and CEO
Tel 561-478-8770, ext. 132

Investor Relations
Scott Liolios or Ron Both
Liolios Group, Inc.
Email: Email Contact
Tel 949-574-3860

Filed Under: Medical And Healthcare

VALLEYLIFE Launches Sponsorship Program and Hosts Open House

Posted on August 10, 2010 Written by Annalyn Frame

SOURCE: VALLEYLIFE

PHOENIX, AZ–(Marketwire – August 10, 2010) –  VALLEYLIFE, a not for profit organization committed to serving individuals with developmental disabilities, launched a sponsorship program to benefit its disabled members and invites the public to attend an open house. For more than 63 years, VALLEYLIFE has provided services to its disabled members so they might not only meet daily essential needs, but to achieve a brighter future with programs that support job training, housing, social activities, and independent living skills. 

Due to a recent termination in state funding, more than 700 disabled citizens in Arizona have been cut from their programs. At VALLEYLIFE, 17 members are directly affected and no longer receive government funding. Despite this, the staff at VALLEYLIFE has continued to provide its members the ongoing support they need. 

“Most of the members directly affected have no family. The staff at VALLEYLIFE has become their family and they, a part of ours. We will continue to provide the programs as long as we can, but without appropriate services, some of our disabled members may end up on the street or in jail,” said Cletus Thiebeau, CEO of VALLEYLIFE.

VALLEYLIFE’s sponsorship program enables local business and private citizens an opportunity to support the community they live in by providing our members with services they need to be independent. The cost to sponsor a member for one hour of service is $4, the cost of a gourmet cup of coffee. The programs range from vocational services where a member is able to earn money, to day treatment program services, where a developmentally disabled member is under the care of a qualified staff member.

VALLEYLIFE prides itself in its low administrative cost of 7 percent; 93 cents of every dollar goes directly into the programs, directly making a difference in the lives of its members. Their motto is: Changing lives. Creating Community. Today, VALLEYLIFE is humbly turning to its community for financial support so that their organization can continue to provide services to a population of people often forgotten, developmentally disabled adults.

Please show your support by calling in a monthly pledge or sending in a one-time donation. The staff at VALLEYLIFE also welcomes the public to an open house at their facility. Donors will see first-hand how even the most modest financial donation goes a long way, directly touching the lives of those who need immediate help and care.

To learn more about VALLEYLIFE, please visit www.VALLEYLIFEaz.org

Contact:
Marlo Sneddon
(602) 216-6378
Email Contact

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

Revenue Cycle Inc. Announces Timely Partnership With The Oncology Group LLC as Cancer Services Market Continues Integration Model

Posted on August 10, 2010 Written by Annalyn Frame

SOURCE: Revenue Cycle Inc.

AUSTIN, TX–(Marketwire – August 10, 2010) –  As a recognized leader in the business of medical and radiation oncology, Revenue Cycle Inc. announces a new partnership with The Oncology Group. The affiliation continues a growing trend for Revenue Cycle, known for its broad-based oncology consulting work and education and training services.

As one of the premier cancer care consulting organizations in the nation, The Oncology Group will join the 3 core businesses that are Revenue Cycle: RC Billing for medical practice coding, billing, insurance submissions and AR management; Revenue Cycle consulting services which offer complete audits to measure charge capture accuracy and standards compliance; and NDevor, a healthcare facilities development company.

“We are pleased to add The Oncology Group as an affiliate and look forward to the continued growth of our companies,” says Revenue Cycle Inc. Chief Executive Officer Ron DiGiaimo. “Recognizing a need for a ‘best of the best’ is part of the company culture, and dictates everything Revenue Cycle does on a daily basis; the merger will increase our combination of resources and expertise.”

President of The Oncology Group Marsha Fountain adds, “The Oncology Group will continue its tradition of customized oncology services consulting and strategic planning for community and academic cancer centers. Our relationship with Revenue Cycle Inc., and their position as a key source of thought leadership within the physician practice arena increases both firms’ influence within an integrating cancer services market.”

The combined activities of both companies will continue The Oncology Group’s focus on all aspects of oncology growth and business management. Leaders from both merger partners agree that the strategic alliance will benefit their clients, as hospitals work to create and sustain integrated 21st century cancer centers and physician practices. For more information about Revenue Cycle Inc., please visit www.revenuecycleinc.com. To contact The Oncology Group visit www.theoncologygroup.com.

Media Contact:
Annie Jones
Rock Candy Media
[email protected]
512.944.0049

Filed Under: Medical And Healthcare

VA Pittsburgh Chooses ClearCount Medical Solutions to Prevent Retained Surgical Sponges

Posted on August 10, 2010 Written by Annalyn Frame

SOURCE: Medline Industries, Inc.

SmartSponge System, Distributed by Medline, Is the Only System to Count and Detect

MUNDELEIN, IL–(Marketwire – August 10, 2010) –  ClearCount Medical Solutions and Medline Industries, Inc. today announced that their newest customers, the VA Pittsburgh Healthcare system, will help prevent retained surgical sponge incidents with the use of the SmartSponge System®. The SmartSponge System is part of ClearCount’s radio-frequency identification (RFID)-based platform that uniquely identifies each sponge so that they can be easily counted and detected. Medline is the exclusive distributor for the SmartWand-DTX and the SmartSponge System, the only FDA-cleared systems using RFID to both count and locate surgical sponges.

“We are pleased to derive the benefits of such a comprehensive solution for the prevention of retained surgical sponges,” said Mark A. Wilson, M.D., Ph.D. Chief Surgeon and Medical Director of the Surgery Specialty Service Line, VA Pittsburgh. “We use the SmartSponge System to improve patient safety in our ORs with the goal of also improving efficiency. The uniqueness of this RFID platform is its integration of both counting and detection strategies. It is capable of growing with our patient safety initiatives, and we look forward to the future benefits it will provide.”

“The SmartSponge System provides a safety net for human error. Despite the level of experience of staff, individuals are bound to make mistakes. Distractions during counting and the mundane simplicity of ‘counting’ make the inevitability of losing track of a sponge a constant reality. The use of a system that virtually eliminates retained sponge incidents allows us to meet our ethical obligation to our patients,” said William Stevens, RN, BSN, CNOR Nurse Manager OR/PACU Surgery Specialty Service Line, VA Pittsburgh.

The VA Pittsburgh hospital has implemented SmartSponge Systems into its full suite of operating rooms. The national Veterans Health system, which includes 155 medical centers and 842 outpatient clinics, is the largest health care system in the US, with more than 5 million of the 25 million veterans alive today receiving its services.

“We’re pleased to add the VA Pittsburgh to our customer base,” said David Palmer, Chief Executive Officer of ClearCount. “The VA Pittsburgh has shown great leadership in terms of innovation and its commitment to patient safety. We are proud to now be a part of that continued tradition.”

Despite designation as a “never event,” retained items are estimated to occur in one of every 1,000 to 1,500 abdominal surgical procedures, which can lead to hospital inefficiencies, unnecessary costs, serious infections and even death. Hospital infections add an estimated $30.5 billion to the nation’s hospital costs each year. In one study using a retrospective review of medical malpractice claims data from a statewide insurer in Massachusetts, sponge counts had been falsely correct in 76 percent of non-vaginal surgical cases involving retained sponges. Falsely correct sponge counts were attributed to team fatigue, difficult or long operations, sponges “sticking together,” shift changes or procedures with a large number of sponges.

About ClearCount Medical Solutions
ClearCount Medical Solutions is a medical device company focused on patient safety solutions. ClearCount has assembled an extendable RFID-based platform that provides a comprehensive solution to improve efficiency while preventing medical errors, distributed exclusively by Medline. ClearCount Medical Solutions has been recognized with a Popular Science 2009 Best of What’s New Award, and has received additional recognition from TIME and WIRED magazines, the 2009 Wall Street Journal Technology Innovation Award, the International Design Excellence Award (IDEA) and more. ClearCount’s SmartSponge and SmartWand-DTX systems are the only RFID enabled systems for counting and detecting surgical sponges, thereby improving patient and OR safety, enhancing productivity, and reducing cost. To learn more, visit www.clearcount.com.

About Medline Industries, Inc. 
Medline, the nation’s largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 100,000 products to hospitals, extended-care facilities, surgery centers, home care dealers and agencies. Headquartered in Mundelein, Ill., Medline has more than 900 dedicated sales representatives nationwide to support its broad product line and cost management services.

Over the past five years, Medline has been the fastest-growing distributor of medical and surgical supplies in the U.S., serving as the primary distributor to over 450 major hospitals and healthcare systems. As a leading distributor, Medline offers a comprehensive array of consulting and management services encompassing the supply chain and logistics, utilization and standardization, business tools and enhanced reporting capabilities and on-staff clinicians.

Medline Media Contacts:
Jerreau Beaudoin
(847) 643-3011
John Marks
(847) 643-3309

ClearCount Medical Solutions:
Jennifer Bannan
(412) 580-3675

Filed Under: Medical And Healthcare

Long Term Care & Nursing Home Information Systems Markets to Reach $674.9 Million by 2016

Posted on August 10, 2010 Written by Annalyn Frame

SOURCE: MarketResearch.com

ROCKVILLE, MD–(Marketwire – August 10, 2010) –  MarketResearch.com has announced the addition of Wintergreen Research’s new report “Long Term Care and Nursing Home Information Systems Market Shares, Strategies, and Forecasts, Worldwide, 2010 to 2016” to their collection of Information Technology market reports. For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=2746054

New long term care information systems have revolutionized the market, creating units that work across the board in long term care situations. This evolution of the software means that clinicians have more flexibility of care decisions, caring for people.

Information systems are emerging as a significant part of the nursing home and long term care delivery systems. All facilities have some kind of automated systems, but this study addresses the industry specific systems that are evolving with industry specific financial management and process integration. Software leverages the efficiency of clinical process in ways that have never become possible before. The electronic patient record can be integrated with financial systems, increasing the efficiency of transmitting services description to the insurance providers.

The ability to capture services delivery electronically at the point of care is central to creating more efficient infrastructure for the providers. The system leverages virtually all the administrative and financial information needed to run a successful home care company. Information can be gathered right from the charts.

The significance of integration systems is not yet realized in nursing home information systems. Collaboration and electronic patient records promise to drive the efficiencies gained from electronic records in to the clinical delivery process, giving caretakers more time to spend with patients. As patients move from one care venue to another, the patient record is going to need to move with them. The hand©held, computer-based system guides home care clinicians through the entire patient care process. Clinicians can use structured record guides. The systems automate reporting.

The fundamental aspect of long term care and nursing home information systems implementation relates to patient treatment flexibility. The ability to be responsive to changing patient conditions is central to the task of controlling nursing home and skilled nursing facility costs. The ability of systems to support flexibility in managing patients to lower cost care delivery sites is anticipated to spur rapid growth of the electronic patient record for these facilities. Long term care and nursing home information systems markets at $225.8 million in 2009 are anticipated to reach $674.9 million by 2016.

Topics covered in the report include…

  • Nursing Home and Long Term Care Information Systems Market Description and Market Dynamics
  • Long Term Care Information Systems
  • Market Shares and Forecasts
  • Long Term Care Information System Product Description
  • Long Term Care Nursing Home Information Systems Technology
  • Long Term Care Nursing Company Profiles

For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=2746054

Contact:
Veronica Franco
MarketResearch.com
[email protected]
240.747.3016

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

Allocade Announces Major New Features for Its Innovative Hospital Operations Management Software

Posted on August 10, 2010 Written by Annalyn Frame

SOURCE: Allocade Inc.

New Capabilities Dramatically Improve Hospital Patient Flow Management and Communication Amongst Caregivers; Compatible With All Web-Enabled Devices Including Smart Phones and Tablets

MENLO PARK, CA–(Marketwire – August 10, 2010) –  Allocade, Inc., the developer of healthcare’s most advanced tools to orchestrate patient flow, today announced the availability of new capabilities in its On-Cue® operations management software suite. On-Cue is powered by an artificial intelligence engine that orchestrates patient flow and automatically adapts to disruptions as they occur, enabling the industry’s only Dynamic Patient Itinerary™ — a time-tagged list of each patient’s preparation and procedure events that adapts in real-time as conditions change. This latest release from Allocade adds options to facilitate communications and manage operations while offloading logistical tasks from clinical staff.

The new capabilities for On-Cue were developed with input from customers. Key features include:

  • An enterprise viewer, which allows access to the software suite from anywhere in the hospital, and from any device that is browser-enabled such as smart phones and tablets with access to the hospital’s network.
  • Electronic protocoling that enables doctors, nurses and technologists to collaborate seamlessly, not only in preparation for procedures, but while they are actually in progress.
  • A portable equipment component that manages the impacts to schedules when staff and equipment go portable in the hospital.

“Allocade continues in its tradition of constant innovation and adaptability with its latest software release,” said Joyce Lasich, Imaging System Administrator, Medical City Dallas Hospital. “We installed the enterprise viewer on all of our front desk computers and we can now ensure a higher quality of patient care and transparency throughout the hospital. We have the ability to view all patients’ imaging schedules with all of the pertinent information for the study with one interface. In addition, caregivers can now send and receive information about the current status of a patient with minimal disruption to workflow, which allows for more time with the patent.”

The immediate and positive response to the new capabilities from customers highlights Allocade’s ongoing commitment to developing software tools that provide powerful capabilities, while remaining simple to use.

Allocade’s Operations Management Software optimizes hospital patient flow for inpatients, outpatients and emergency patients. The software uses technology initially developed to manage workflow on the Hubble Space Telescope by Don Rosenthal, founder and chief technology officer of Allocade. The company’s patented Schedule Repair™ technology augments information already available in Hospital Information Systems (HIS), Radiology Information Systems (RIS) and Electronic Medical Record Systems (EMR) by adding layer of intelligence to these systems.

Allocade and On-Cue were prominently featured in the 2009 issue of NASA Spinoff; an annual book featuring successfully commercialized NASA technology. Allocade was also invited to participate in the May 2010 NASA Spinoff Day on the Hill, where it showcased On-Cue for members of Congress and NASA representatives.  

About Allocade
 
Allocade, Inc. was founded in 2004 and is headquartered in Menlo Park, Calif. The company is a healthcare software company that develops tools to intelligently optimize patient flow throughout the hospital enterprise. Allocade’s first product is the On-Cue® Hospital Operations Management solution. The company’s management team includes former top executives from the NASA Ames Research Center, Siemens Medical Systems, Philips Medical Systems, Fujifilm Corporation, and Stentor. For more information, visit http://www.allocade.com.

On-Cue is a registered trademark, and Dynamic Patient Itinerary and Schedule Repair are trademarks of Allocade, Inc.

Media Contact:
Amy Cook
925.552.7893
Email Contact

Filed Under: Medical And Healthcare

DiaMedica Announces Dr. Michael Giuffre to Join Board of Directors

Posted on August 10, 2010 Written by Annalyn Frame

WINNIPEG, MANITOBA–(Marketwire – Aug. 10, 2010) – DiaMedica Inc. (TSX VENTURE:DMA) today announced the appointment of Dr. Michael Giuffre to the company’s Board of Directors.

Dr. Giuffre is a Clinical Professor of Cardiac Sciences and Pediatrics at the University of Calgary. Dr Giuffre is currently a member on the board’s of the Alberta Medical Association and Unicef Canada. He is a past representative to the board of the Calgary Health Region and is an active participant in the biotechnology business sector.

“Dr. Giuffre’s clinical and business experience, particularly with his extensive cardiovascular background, will add additional depth to our Board,” stated Mr. Rick Pauls, President and CEO of DiaMedica.

“I am pleased to be joining the Board of Directors of DiaMedica at such a progressive time in its history,” stated Dr. Giuffre. “DiaMedica has very promising technology and I look forward to leveraging my experience as the company prepares for exciting and ambitious milestones.”

About Dr. Michael Giuffre

As a Clinical Professor of Cardiac Sciences and Pediatrics at the University of Calgary, Dr Giuffre maintains a portfolio of clinical practice, cardiovascular research, and university teaching. He maintains on-going involvement in both health care administration, and in the biotechnology business sector. Dr Giuffre is Past President of the Calgary and Area Physicians Association (CAPA) and a past representative to the board of the Calgary Health Region. Dr Giuffre holds a BSc in cellular and microbial biology, a PhD candidacy in molecular virology, an MD and an MBA. His Canadian Royal College board certified specialties include Pediatrics, Pediatric Cardiology and a subspecialty in Pediatric Electrophysiology.

As a biotechnology consultant, Dr. Giuffre has been involved with RedSky Inc. (acquired by Research in Motion), MDMI, and MedMira Inc. He is currently on the boards of IC2E Inc and FoodChek Inc. He serves on the Medical Advisory Board of the SADS Foundation and on the boards of Unicef Canada and the Alberta Medical Association. He is also an MD-MP contact for the Canadian Medical Association.

Dr Giuffre has recently received a Certified and Registered Appointment by the American Academy of Cardiology, “Distinguished Fellow of the American Academy of Cardiology,” and in 2005 was awarded “Physician of the Year” by the Calgary Medical Society.

About DiaMedica

DiaMedica is a biopharmaceutical company focused on developing novel treatments for diabetes and neurological disorders. The Company’s type 2 diabetes program is based on a critical liver nerve signaling mechanism involved in enhancing insulin sensitivity after meal consumption. Two of DiaMedica’s products, DM-71 and DM-99, have previously demonstrated human efficacy in lowering blood sugar levels in people diagnosed with type 2 diabetes based on this novel nerve signaling mechanism.

DiaMedica has expanded its DM-199 recombinant protein program into neurological and autoimmune disorders. The Company has demonstrated that DM-99, the naturally occurring form of DM-199, confers neural protection (protects brain cells) and triggers neural stem cell proliferation (creates brain cells) for the treatment of numerous neurological disorders including Alzheimer’s disease. DiaMedica is listed on the TSX Venture Exchange under the trading symbol “DMA”. For further information please visit www.diamedica.com.

Caution Regarding Forward-Looking Information

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable Canadian provincial securities legislation (collectively, the “forward-looking statements“). These forward-looking statements relate to, among other things, DiaMedica’s objectives, goals, targets, strategies, intentions, plans, beliefs, estimates and outlook, and can, in some cases, be identified by the use of words such as “believe,” “anticipate,” “expect,” “intend,” “plan,” “will,” “may” and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Specifically, this press release contains forward-looking statements regarding matters such as, but not limited to, the prospective Offering and the proceeds from the Offering, the anticipated use of proceeds from the Offering, regulatory approval of the Offering, and our other plans, estimates and expectations, including the completion of our proposed acquisition of Sanomune Inc. These statements reflect management’s current beliefs and are based on information currently available to management. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Important factors that could cause actual results to differ materially from these expectations include, among other things: uncertainties and risks related to our ability to complete the Offering, the availability of financing, risks and uncertainties relating to the anticipated use of proceeds, changes in debt and equity markets, uncertainties related to clinical trials and product development, rapid technological change, uncertainties related to forecasts, competition, potential product liability, additional financing requirements and access to capital, unproven markets, the cost and supply of raw materials, management of growth, effects of insurers’ willingness to pay for products, risks related to regulatory matters and risks related to intellectual property matters. 
Additional information about these factors and about the material factors or assumptions underlying such forward-looking statements may be found in the body of this news release, as well as under the heading “Risk Factors” contained in DiaMedica’s 2008 annual information form. DiaMedica cautions that the foregoing list of important factors that may affect future results is not exhaustive. When relying on DiaMedica’s forward-looking statements to make decisions with respect to DiaMedica, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Such forward-looking statements are based on a number of estimates and assumptions which may prove to be incorrect, including, but not limited to, assumptions regarding the availability of financing for research and development companies, general business and economic conditions, and DiaMedica’s ability to complete its proposed acquisition of Sanomune Inc. These risks and uncertainties should be considered carefully and investors and others should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this press release are based upon what management believes to be reasonable assumptions, DiaMedica cannot provide assurance that actual results will be consistent with these forward-looking statements. DiaMedica undertakes no obligation to update or revise any forward-looking statement. Additional risk factors, factors which could cause actual results to differ materially from expectations, and assumptions relating specifically to our proposed acquisition of Sanomune Inc. may be found in our press release dated February 18, 2010.

Filed Under: Medical And Healthcare

FDA Approves Innovative Liver Cell Therapy for Clinical Trial in the U.S.

Posted on August 10, 2010 Written by Annalyn Frame

SOURCE: Cytonet

WEINHEIM, GERMANY–(Marketwire – August 10, 2010) – On July 23, 2010 the liver cell preparation by Cytonet GmbH & Co. KG received an Investigational New Drug allowance (IND) from the U.S. Food and Drug Administration (FDA). This is the first time a later stage clinical trial with liver cell therapy can now be started in the US. The FDA-approval is partly based on interim results of an ongoing clinical trial in Germany with neonatal patients suffering from urea cycle disorders (UCD). Cytonet will immediately start the clinical trial SELICA (Safety and Efficacy of Liver Cell Application)-III. The objective of this open, prospective, group-matched, historic-controlled multi-center study is to investigate the safety and efficacy of liver cell therapy in children suffering from UCD. Five therapy centers, as well as 10 centers actively assigning patients and responsible for the after-care, are participating in the SELICA-III trial. 

This study is the second clinical study on liver cell therapy in children suffering from UCD. The first trial, SELICA-II, has been running in Germany for approximately 1 year. SELICA-III comprises a six-month treatment and observation phase and a subsequent 18-month follow-up. The study includes infants, toddlers and children up to the age of five, who are suffering from the most severe forms of the following UCDs: ornithine transcarbamylase (OTC) deficiency, carbamoyl­phosphate synthetase I (CPS I) deficiency or argininosuccinate-synthetase (ASS) deficiency, also called citrullinemia. Cytonet would like to acknowledge the National Urea Cycle Disorders Foundation for its assistance during the development of the program. For more information about urea cycle disorders, visit the National Urea Cycle Disorders Foundation at www.nucdf.org.

About urea cycle disorders and liver cell therapy
UCDs are severe and life-threatening disorders of the ammonia (NH3) metabolism of the liver. These include carbamoylphosphate synthetase I (CPS) deficiency, N-acetylglu­tamate-synthetase (NAGS) deficiency, ornithine-transcarbamylase (OTC) deficiency, argininosuccinate-synthetase (ASS) deficiency — also known as citrullinemia, arginino­succinate-lyase (ASL) deficiency and arginase 1 deficiency (hyper­argi­ninemia). UCDs are based on disorders of 6 known enzymes that are involved in NH3-detoxification. In UCD-patients, the neurotoxic NH3 is not metabolized into urea and excreted. Instead, it accumulates in the blood and tissue. Depending on the severity of the disease, it leads to massive damage of the nerves and the brain, and can be fatal. Children who remain untreated rarely have a normal physical and mental development.

The only currently available cure is the transplantation of a whole liver or a liver lobe. However, this treatment is highly problematic for very young children and neonatal patients. Additionally, suitable organs available for transplantation are very rare. A therapy using isolated and processed liver cells from non-transplantable donated livers (manufactured under GMP standards) has been investigated and further developed over the past years. Cytonet is working in close cooperation with internationally leading neonatal and pediatric metabolism centers. The overall goal is an effective compensation of the metabolism disorder by means of the infusion of healthy, fully metabolism-competent human liver cells into the portal vein, subsequently engrafting in the liver of the child with the disorder.

About Cytonet
The Cytonet Group is an international biotechnology company with sites in Weinheim, Heidelberg and Hannover, Germany and Durham, NC, USA. Currently Cytonet has 60 employees. The company develops, produces and markets cell-therapeutic products for many diseases. In the process developed by Cytonet, liver cells from donated livers are gently isolated and cleaned up in a complex procedure. The donor livers, which are obtained from Organ Procurement Organizations in the United States, are unsuitable for organ transplantation. Additionally, Cytonet provides blood stem cell and bone marrow preparations for the therapy of leukemia and other malignant diseases. Managing directors are Dr. Wolfgang Rüdinger and Dipl.-Kfm. (MBA) Michael J. Deissner. Cytonet was founded by the demerger of the Cell Therapy department from the Roche Group in April 2000. The Dietmar Hopp family owns the majority of shares.

Please contact at Cytonet:
Cytonet LLC
Mark Johnston
801 Capitola Drive,
Suite 8, Durham,
NC 27713, USA
[email protected]

Cytonet GmbH & Co. KG
Sina Oelenheinz
Albert-Ludwig-Grimm-Str. 20
69469 Weinheim
Germany
fon: +49 6201 – 2598 133
fax: +49 6201 – 259828
email: [email protected]

August 10, 2010
4640 characters (incl. blank spaces, without headline)
Reprints free of charge, sample copies appreciated

Press contact:
Cramer-Gesundheits-Consulting GmbH
Postfach 11 07
65741 Eschborn
Germany

Karin Jürgens
Tel. +49 61 96 / 77 66 – 114
[email protected]

Kerstin Depmer
Tel. +49 61 96 / 77 66 – 117
[email protected]

Filed Under: Medical And Healthcare

Print Dental Marketing Remains Essential Part of Marketing Mix, Says Patient News

Posted on August 10, 2010 Written by Annalyn Frame

SOURCE: Patient News

NEW YORK, NY and TORONTO–(Marketwire – August 10, 2010) –  A diverse marketing mix that includes and addresses communication preferences of readers is essential to any marketing or advertising campaign, and print marketing and direct mail still remain an integral part of that mix, says Patient News, a leading dental marketing solutions company.

“Statistics show that most marketers have found that online channels demonstrate greater value when distributed in conjunction with direct mail applications, reinforcing the value of print in the marketing mix,” said Karen Galley, President of Patient News.

Baby Boomers, who have an annual spending power of $2.1 trillion and account for upwards of 60% of all healthcare spending, actively shop through the mail and keep mail pieces for future reference. According to a research study by JWT BOOM and ThirdAge Inc., 90% of Baby Boomer women surveyed have seen a print ad and later visited the online site. As women make more than 85% of all healthcare buying decisions, this adds up to significant business that can be attributed to print marketing such as newsletters, direct mail or custom postcards.

In addition, the coveted 18-49 consumer group welcomes, reads and responds to printed materials. Close to 90% of this group sort through mail immediately, nearly 80% read direct mail advertising, and about 70% use coupons received in the mail.

“Print is an amazing online traffic generator, and it delivers consistent response rates,” said Galley. “People are more willing to try new brands than ever before, and those over 50 years old, the primary target for most of our dentists, are more likely than any other group to read and respond to direct mail pieces.”

For additional information on dental newsletters, variable data services, dental postcards, printed or e-dental advertising from Patient News call 800.667.0268 or visit www.Patientnews.com.

To read more on this topic, visit: http://www.patientnews.com/pressreleases/print-dental-marketing-in-mix.html.

About Patient News:

Patient News is North America’s most comprehensive and innovative provider of direct mail, newsletters, postcards, email newsletters, and referral cards. Founded in 1992, the company produces award-winning healthcare and dental marketing products in Canada, the United States, and the United Kingdom.

Contact:

Joanne Bishop
Vice-President
Patient News
800-667-0268

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

Médicos del Hospital Mount Sinai derrumban los mitos sobre el verano entre los latinos y dan consejos para una vida saludable

Posted on August 9, 2010 Written by Annalyn Frame

SOURCE: The Mount Sinai Medical Center

NUEVA YORK, NY–(Marketwire – August 9, 2010) – El verano es tiempo para practicar deportes
al aire libre, disfrutar de un asado con familiares y amigos, salir al
campo, ir la playa y mucho más. Sin embargo, algunas creencias comunes
entre la comunidad Hispana podrían estar impidiendo a esta comunidad
disfrutar de su salud. Por eso, un equipo de médicos del Hospital Mount
Sinai aclara cuatro de los mitos más comunes sobre el verano entre los
latinos.

1. Piel morena no necesita protección solar

“Es un error común entre los latinos creer que si el tono de piel es
oscuro, no es necesario protector solar. Para evitar el cáncer en la piel,
todos los latinos, sin importar su color de piel, deben aplicar protector
solar cada 30 minutos, la primera aplicación 30 minutos antes de exponerse
al sol y cubriendo todas las áreas que se expondrán al sol, con mínimo dos
onzas de bloqueador cada vez”, dice el Doctor y Cardiologo Samer Kottiech,
añadiendo, “no importa donde esté; asegúrese de usar protector solar. Si se
encuentra al aire libre necesita protector solar”.

2. Tomando café, gaseosas y cervezas, no necesito agua

Con temperaturas de más de 90 grados, el cuerpo debe estar hidratado y
pocas bebidas, hidratan su cuerpo como el agua. “El agua no es la opción
más popular entre los latinos”, dice el Doctor Carlos Driggs, especialista
en medicina interna, y agrega, “para evitar deshidratación, lo mejor es
tomar entre 1 y 2 vasos de agua por hora cuando se está al aire libre, si
se consume alcohol o hace ejercicio, se recomiendan 2-3 vasos por hora,
especialmente con temperaturas cada vez más altas. Asegúrese de llevar su
botella durante los días calurosos”.

3. Si la comida está cocinada, no se daña

Las clínicas reciben cada verano pacientes intoxicados por alimentos no
refrigerados adecuadamente. Las actividades al aire libre son muy populares
entre los latinos, lo cual aumenta los riesgos para esta población durante
le verano. El doctor Rajeev Sindhwani, especialista en cuidado
cardiovascular, recomienda, “se puede evitar intoxicación siguiendo 5
reglas: 1. tener manos limpias para manejar alimentos; 2. usar una tabla
para picar carne y otra para vegetales; 3. no dejar los alimentos al aire
libre por tiempo prolongado; 4. asegurarse que las carnes estén bien
cocidas; y 5. limpiar la parrilla antes de cocinar alimentos frescos, para
evitar la contaminación de residuos de otros alimentos cocidos”.

4. Si usted elimina la grasa, se pierde el sabor

“Existe la idea de que quitar la piel del pollo o reducir la grasa de la
carne, hará que la comida pierda sabor. Todos los alimentos, pueden tener
un sabor exquisito incorporando especias, frutas y verduras”, dice el Dr.
Eliscer Guzman, MD FACC, y agrega, “eso ayudará a que los latinos disfruten
una vida libre de dos de las enfermedades que más afectan a esta comunidad,
la diabetes y las enfermedades cardiovasculares”.

Guzmán también recomienda aprovechar las frutas frescas que son abundantes
durante el verano y están disponibles a buen precio. “Su barbacoa debe
tener tantos colores como alimentos saludables existen, verdes, amarillos,
rojos. También hay que cuidar los tamaños de las porciones, para medir el
tamaño de la carne, por ejemplo, asegúrese que esta sea del tamaño de la
palma de su mano”, agrego el Dr. Guzmán.

“Recuerde mantener su parrilla limpia, si quiere darle sabor de asado a sus
platos, puede usar un poco de carbón con sus condimentos predilectos, para
darle el toque de asado y el sabor a su carne”, recomendó El Dr. Guzmán.

Acerca del Centro Médico Mount Sinai

El Centro Médico Mount Sinai incluye el Hospital Mount Sinai y el Colegio
de Medicina. Desde 1968, es uno de los pocos colegios médicos en EEUU parte
de un hospital, con más de 3,400 profesores, 32 departamentos y 15
instituciones, es uno de los 20 colegios médicos según el Instituto
Nacional de Salud y U.S. News & World Report. El Hospital Mount Sinai, se
fundó en 1852, cuenta con 1,171 camas. Es uno de los más antiguos, grandes
y respetados hospitales del país. En el 2009, fue clasificado dentro de los
20 hospitales principales de la nación. Más de 60,000 personas fueron
atendidas en el Mount Sinai en 2009 y recibió aproximadamente 530,000
visitas de pacientes.

Más información visite www.mountsinai.org o síganos en Twitter
@mountsinainyc.

Filed Under: Facilities And Providers

Mount Sinai Hospital Physicians Debunk Common Summertime Myths Among Latinos and Provide Tips for Healthy Living

Posted on August 9, 2010 Written by Annalyn Frame

SOURCE: The Mount Sinai Medical Center

NEW YORK, NY–(Marketwire – August 9, 2010) –  Summer is the time for playing outdoor sports, eating at picnics and BBQs with family and friends. However, some commonly made mistakes keep Latinos for being healthy. That is why a team of physicians at Mount Sinai Hospital took it upon themselves to debunk four of the most common summertime myths among Latinos.  

1. Since some Latinos have dark skin, they believe that they don’t need sunscreen
“A misunderstanding among Latinos is that, because many have dark skin tones, sunscreen is not necessary,” says Dr. Samer Kottiech, M.D. and Cardiologist. “However, to avoid skin cancer, everyone needs to frequently apply sunscreen regardless of their skin tone,” he adds. Dr. Kottiech recommends reapplying the sunscreen every 30 minutes after the first application. Also, be sure to cover your entire body and use at least one shot glass of sunscreen with each application.

2. If I drink beverages like coffee, soda and beer, I do not need water
With temperatures rising, it’s critical that your body is well hydrated. “Water is not the popular drink among most Latinos,” says Dr. Carlos Driggs, MD and specialist in Internal Medicine. “However, in order to avoid heat stroke, it is best to drink between 1-2 glasses of water before going outdoors, especially during summer.” Also, Dr. Driggs suggests to increase the consumption of water by 2 glasses an hour, if you are drinking alcohol or exercising, making sure you carry a bottle of water with you at all times to keep hydrated.

3. If food is cooked, it can’t spoil
During summer, emergency rooms see a lot of patients who contracted food poisoning due to food that was not properly refrigerated. Since outdoor eating functions are so popular among Latinos, they are often impacted. “One commonly made mistake is to leave food outside after a picnic or BBQ,” adds Dr. Rajeev Sindhwani, MD, Cardiovascular Disease Physician. “You can avoid food poisoning by following a few simple rules: 1. Handle food with clean hands; 2. Use separate cutting boards for meats and vegetables; 3. Don’t leave food outdoors; 4. Use a meat thermometer to ensure meat is cooked thoroughly,” and 5. Make sure to clean the grill or cover it with aluminum foil before cooking any fresh meat or vegetables to avoid contamination from previously cooked food residue.

4. If you trim the fat, you lose the flavor
Another misconception among Latinos, is if they remove the skin from their chicken or trim the fat from their beef, their food will be tasteless. “Meats will taste just as flavorful by incorporating a variety of spices, fruits and vegetables,” says Dr. Eliscer Guzmán, M.D. F.A.C.C. “By taking this approach, Latinos will live a healthier life and avoid cardiovascular diseases and diabetes, two diseases currently plaguing the Latino community.” Dr. Guzman recommends taking advantage of the abundant fresh fruits during the summer that are available at a reasonable price.

Dr. Guzmán adds, “Portions sizes can make a tremendous difference to your overall health also. A common rule of thumb for portions is to make sure the size of meat is roughly the size of the palm of your hand.”

About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine is one of few medical schools embedded in a hospital in the United States. It has more than 3,400 faculty in 32 departments and 15 institutes. The school received the 2009 Spencer Foreman Award for Outstanding Community Service from the Association of American Medical Colleges.

The Mount Sinai Hospital, founded in 1852 is one of the nation’s oldest, largest and most-respected voluntary hospitals. In 2009,The Mount Sinai was ranked among the nation’s top 20 hospitals Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 530,000 outpatient visits took place.

For more information, visit www.mountsinai.org. Follow us on Twitter @mountsinainyc.

Filed Under: Facilities And Providers

Assisted Living Concepts, Inc. Announces Continued Strategy Successes; Reports Fourth Consecutive Quarter of Revenue and Private Pay Occupancy Growth

Posted on August 9, 2010 Written by Annalyn Frame

SOURCE: Assisted Living Concepts, Inc.

MENOMONEE FALLS, WI–(Marketwire – August 9, 2010) – Assisted Living Concepts, Inc. (NYSE: ALC)

Highlights:

--  Increased average private pay occupancy by 122 and 8 units over the
    second quarter of 2009 and the first quarter of 2010, respectively
--  Increased overall and private pay rates by 5.8% and 3.8%, respectively
    over the second quarter of 2009
--  Increased Adjusted EBITDAR as a percent of revenues to 33.6%, up from
    32.3% in both the second quarter of 2009 and the first quarter of 2010
--  Adjusted EBITDAR as a percent of revenues would have been a record
    34.4% (excluding One-Time Charges)
--  Extended and expanded share repurchase program authorizing up to
    $15 million through August 9, 2011

Assisted Living Concepts, Inc. (“ALC”) (NYSE: ALC) reported net income of
$2.9 million in the second quarter of 2010. During the second quarter of
2010, ALC recorded the following “One-Time Charges”: an impairment charge
relating to a non-cash write-down of certain equity investments ($1.3
million net of income tax benefits); expenses associated with the
realignment of our divisions ($0.3 million net of income tax benefits);
and write-off of expenses incurred with an expansion project that the
company decided not to complete ($0.1 million net of income tax benefits).
Excluding the One-Time Charges, net income in the second quarter of 2010
would have been $4.6 million as compared to net income of $3.9 million in
the second quarter of 2009.

“Second quarter operating results were solid. For the fourth quarter in a
row we achieved positive private pay occupancy and revenue growth,”
commented Laurie Bebo, President and Chief Executive Officer. “Despite
continuing challenges in the economy and in particular with high
unemployment rates, we continue to be confident in our ability to increase
private pay occupancy and Adjusted EBITDAR margins throughout 2010.”

For the first six months of 2010, ALC reported net income of $6.5 million.
Excluding the One-Time Charges, net income for the first six months of 2010
would have been $8.2 million compared to a net loss from continuing
operations and a net loss of $7.7 million and $7.9 million in the first
six months of 2009, respectively. Excluding an impairment charge related
to the non-cash, non-recurring write-off of all goodwill ($14.7 million net
of income tax benefits) recorded in the first quarter of 2009, net income
from continuing operations and net income for the first six months of 2009
would have been $7.0 million and $6.8 million, respectively.

Diluted earnings per common share for the second quarter and the first six
months ended June 30, 2010 and 2009 were:

                                        Quarter ended    Six months ended
                                           June 30,          June 30,
                                        2010     2009     2010     2009
                                       ------   ------   ------   ------
Diluted earnings (loss) per common
 share from continuing operations      $ 0.25   $ 0.33   $ 0.55   $(0.65)
Diluted earnings (loss) per common
 share                                 $ 0.25   $ 0.33   $ 0.55   $(0.66)
Pro forma diluted earnings per common
 share from continuing operations
 excluding One-Time Charges            $ 0.39   $ 0.33   $ 0.70   $ 0.59(1)

(1) Excludes the goodwill write-off, net of income tax benefits.

One-Time Charges in the quarter ended June 30, 2010 resulted from:

1.  The reclassification of a decline in the fair market value of equity
    securities from a component of the Company's stockholders' equity to
    the Company's income statement. These equity securities represent
    legacy investments transferred from Extendicare Inc. in connection with
    the capitalization of ALC in November 2006.
2.  The realignment of ALC's divisional level management structure. In
    connection with this realignment, ALC incurred certain expenses
    primarily related to personnel.
3.  The decision not to complete an expansion project due to higher than
    anticipated site costs. We continue to evaluate existing owned
    properties for expansion growth.

Certain non-GAAP financial measures are used in the discussions in this
release in assessing the performance of the business. See attached tables
for definitions of Adjusted EBITDA and Adjusted EBITDAR, reconciliations of
net income (loss) to Adjusted EBITDA and Adjusted EBITDAR, calculations of
Adjusted EBITDA and Adjusted EBITDAR as a percentage of total revenues, and
non-GAAP financial measure reconciliation information.

As of June 30, 2010, ALC operated 211 senior living residences comprising
9,280 units.

The following discussions include the impact of the One-Time Charges and
exclude the impact of discontinued operations unless otherwise specified.

Quarters ended June 30, 2010, June 30, 2009, March 31, 2010

Revenues of $58.3 million in the second quarter ended June 30, 2010
increased $1.6 million or 2.9% from $56.7 million in the second quarter of
2009 and increased $0.4 million or 0.8% from the first quarter of 2010.

Adjusted EBITDA for the second quarter of 2010 was $14.5 million or 24.9%
of revenues and

--  increased $1.2 million or 9.1% from $13.3 million and 23.4% of revenues
    in the second quarter of 2009; and
--  increased $0.9 million or 6.7% from $13.6 million and 23.5% of revenues
    in the first quarter of 2010.

Adjusted EBITDAR for the second quarter of 2010 was $19.6 million or 33.6%
of revenues and

--  increased $1.3 million or 7.3% from $18.3 million and 32.3% of revenues
    in the second quarter of 2009; and
--  increased $0.9 million or 5.0% from $18.7 million and 32.3% of revenues
    in the first quarter of 2010.

Second quarter 2010 compared to second quarter 2009

Revenues in the second quarter of 2010 increased from the second quarter of
2009 primarily due to higher average daily revenue as a result of rate
increases ($2.2 million) and an increase in private pay occupancy ($1.2
million), partially offset by the planned reduction in the number of units
occupied by Medicaid residents ($1.8 million). Average private pay rates
increased in the second quarter of 2010 by 3.8% over average private pay
rates for the second quarter of 2009. Average overall rates, including the
impact of improved payer mix, increased in the second quarter of 2010 by
5.8% over comparable rates for the second quarter of 2009.

Both Adjusted EBITDA and Adjusted EBITDAR increased in the second quarter
of 2010 primarily due to an increase in revenues discussed above ($1.6
million) and a decrease in residence operations expenses ($0.5 million)
(this excludes the loss on disposal of fixed assets), partially offset by
an increase in general and administrative expenses ($0.8 million) (this
excludes non-cash equity based compensation) and, for Adjusted EBITDA only,
an increase in residence lease expense ($0.1 million). Residence
operations expenses decreased primarily from lower labor expenses.
Staffing needs in the second quarter of 2010 as compared to the second
quarter of 2009 decreased primarily because of a decline in the number of
units occupied by Medicaid residents who tend to have higher care needs
than private pay residents. In addition, general economic conditions
enabled us to hire new employees at lower wage rates. General and
administrative expenses increased as a result of expenses associated with
an all-company conference held in the second quarter of 2010 and expenses
associated with the realignment of our divisions.

Second quarter 2010 compared to the first quarter 2010

Revenues in the second quarter of 2010 increased from the first quarter of
2010 primarily due to one additional day in the second quarter ($0.6
million), an increase in the number of units occupied by private pay
residents ($0.1 million), and higher average daily revenue as a result of
rate increases ($0.1 million), partially offset by the planned reduction in
the number of units occupied by Medicaid residents ($0.4 million).

Increased Adjusted EBITDA and Adjusted EBITDAR in the second quarter of
2010 as compared to the first quarter of 2010 resulted primarily from a
decrease in residence operations expenses ($0.9 million) (this excludes the
loss on disposal of fixed assets) and an increase in revenues discussed
above ($0.4 million), partially offset by an increase in general and
administrative expenses ($0.4 million) (this excludes non-cash equity-based
compensation). Residence operations expenses decreased primarily from
decreases in utility expenses resulting from normal seasonal fluctuations.
General and administrative expenses increased as a result of expenses
associated with an all-company conference held in the second quarter of
2010 and expenses associated with the realignment of our divisions.

Six months ended June 30, 2010 and June 30, 2009

Revenues of $116.2 million in the six months ended June 30, 2010 increased
$2.4 million or 2.1% from $113.8 million in the six months ended June 30,
2009.

Adjusted EBITDA for the six months ended June 30, 2010 was $28.1 million,
or 24.2% of revenues and

--  increased $3.3 million or 13.1% from $24.8 million and 21.8% of
    revenues in the six months ended June 30, 2009.

Adjusted EBITDAR for the six months ended June 30, 2010 was $38.3 million,
or 33.0% of revenues and

--  increased $3.5 million or 10.2% from $34.7 million and 30.6% of
    revenues in the six months ended June 30, 2009.

Six months ended June 30, 2010 compared to six months ended June 30, 2009

Revenues in the six months ended June 30, 2010 increased from the six
months ended June 30, 2009 primarily due to higher average daily revenue
from rate increases ($4.2 million) and an increase in private pay occupancy
($2.1 million), partially offset by the planned reduction in the number of
units occupied by Medicaid residents ($3.9 million). Average private pay
rates increased in the six months ended June 30, 2010 by 3.8% over average
private pay rates for the six months ended June 30, 2009. Average overall
rates, including the impact of improved payer mix, increased in the six
months ended June 30, 2010 by 5.6% over the comparable rates for the six
months ended June 30, 2009.

Both Adjusted EBITDA and Adjusted EBITDAR increased in the six months ended
June 30, 2010 primarily from a decrease in residence operations expenses
($2.2 million) (this excludes the loss on disposal of fixed assets), and
the increase in revenues discussed above ($2.4 million), partially offset
by an increase in general and administrative expenses ($1.1 million) (this
excludes non-cash equity based compensation) and, for Adjusted EBITDA only,
an increase in residence lease expense ($0.3 million). Residence
operations expenses decreased primarily from lower labor and kitchen
expenses. Staffing needs in the six months ended June 30, 2010 as compared
to the six months ended June 30, 2009 decreased primarily because of a
decline in the number of units occupied by Medicaid residents who tend to
have higher care needs than private pay residents. In addition, general
economic conditions enabled us to hire new employees at lower wage rates.
Kitchen expenses were lower due to new group purchasing plans and lower
overall occupancy. General and administrative expenses increased primarily
from upfront costs associated with transitioning payroll and benefits from
a third party vendor to in-house, expenses associated with an all-company
conference held in the second quarter of 2010, and expenses associated with
the realignment of our divisions.

Liquidity

At June 30, 2010 ALC maintained a strong liquidity position with cash of
approximately $12.2 million and undrawn lines of $70 million.

Share Repurchase Program

On August 9, 2010, ALC’s Board of Directors extended and expanded its share
repurchase program by authorizing the purchase of up to $15 million in
Class A common stock through August 9, 2011. In 2010, through August 9,
2010, ALC repurchased 61,461 shares of Class A Common Stock at a cost of
$1.9 million and an average price of $30.45 per share (excluding fees).

Investor Call

ALC has scheduled a conference call for tomorrow, August 10, 2010 at 10:00
a.m. (ET) to discuss its financial results for the second quarter. This
earnings release will be posted on ALC’s website at www.alcco.com. The
toll-free number for the live call is (800) 230-1096 or international (612)
332-0107; the conference name is “ALC Second Quarter Results.” A taped
rebroadcast of the conference call will be available approximately three
hours following the live call until midnight on September 10, 2010, by
dialing toll free (800) 475-6701, or international (320) 365-3844; the
access code is 165684.

About Us

Assisted Living Concepts, Inc. and its subsidiaries operate 211 senior
living residences comprising 9,280 residents in 20 states. ALC’s senior
living facilities typically consist of 40 to 60 units and offer residents a
supportive, home-like setting and assistance with the activities of daily
living. ALC employs approximately 4,100 people.

Forward-looking Statements

Statements contained in this release other than statements of historical
fact, including statements regarding anticipated financial performance,
business strategy and management’s plans and objectives for future
operations, including management’s expectations about improving occupancy
and private pay mix, are forward-looking statements. Forward-looking
statements generally include words such as “expect,” “point toward,”
“intend,” “will,” “indicate,” “anticipate,” “believe,” “estimate,” “plan,”
“strategy” or “objective.” Forward-looking statements are subject to risks
and uncertainties that could cause actual results to differ materially from
those expressed or implied. In addition to the risks and uncertainties
referred to in the release, other risks and uncertainties are contained in
ALC’s filings with United States Securities and Exchange Commission and
include, but are not limited to, the following: changes in the health care
industry in general and the senior housing industry in particular because
of governmental and economic influences; changes in general economic
conditions, including changes in housing markets, unemployment rates and
the availability of credit at reasonable rates; changes in regulations
governing the industry and ALC’s compliance with such regulations; changes
in government funding levels for health care services; resident care
litigation, including exposure for punitive damage claims and increased
insurance costs, and other claims asserted against ALC; ALC’s ability to
maintain and increase census levels; ALC’s ability to attract and retain
qualified personnel; the availability and terms of capital to fund
acquisitions and ALC’s capital expenditures; changes in competition; and
demographic changes. Given these risks and uncertainties, readers are
cautioned not to place undue reliance on ALC’s forward-looking statements.
All forward-looking statements contained in this report are necessarily
estimates reflecting the best judgment of the party making such statements
based upon current information. ALC assumes no obligation to update any
forward-looking statement.

                   ASSISTED LIVING CONCEPTS, INC.
              Consolidated Statements of Operations
             (In thousands, except earnings per share)

                                Three Months Ended    Six Months Ended
                                     June 30,             June 30,
                               --------------------- ---------------------
                                 2010      2009(1)     2010      2009(1)
                               ---------- ---------- ---------- ----------
Revenues                       $   58,305 $   56,683 $  116,164 $  113,750
Expenses:
  Residence operations
   (exclusive of depreciation
   and amortization and
   residence lease expense
   shown below)                    34,805     35,181     70,517     72,434
  General and administrative        4,256      3,341      8,030      6,775
  Residence lease expense           5,111      4,993     10,194      9,923
  Depreciation and amortization     5,698      5,218     11,368     10,149
    Goodwill impairment                --         --         --     16,315
                               ---------- ---------- ---------- ----------
  Total operating expenses         49,870     48,733    100,109    115,596
                               ---------- ---------- ---------- ----------
Income (loss) from operations       8,435      7,950     16,055     (1,846)
Other expense:
    Other-than-temporary
     investments impairment        (2,026)        --     (2,026)        --
    Interest income                     4          7          8         19
  Interest expense                 (1,899)    (1,834)    (3,787)    (3,537)
                               ---------- ---------- ---------- ----------
Income (loss) from continuing
 operations before income
 taxes                              4,514      6,123     10,250     (5,364)
Income tax expense                 (1,618)    (2,182)    (3,741)    (2,326)
                               ---------- ---------- ---------- ----------
Net income (loss) from
 continuing operations              2,896      3,941      6,509     (7,690)
Loss from discontinued
 operations, net of tax                --        (34)        --       (178)
                               ---------- ---------- ---------- ----------
Net income (loss)              $    2,896 $    3,907 $    6,509 $   (7,868)
                               ========== ========== ========== ==========
Weighted average common shares:
  Basic                            11,567     11,808     11,572     11,882
  Diluted                          11,738     11,927     11,741     11,882
Per share data:
  Basic earnings per common
   share
  Earnings (loss) from
   continuing operations       $     0.25 $     0.33 $     0.56 $    (0.65)
  Loss from discontinued
   operations                          --         --         --      (0.01)
                               ---------- ---------- ---------- ----------
  Net income (loss)            $     0.25 $     0.33 $     0.56 $    (0.66)
                               ========== ========== ========== ==========

    Diluted earnings per
     common share
  Earnings (loss) from
   continuing operations       $     0.25 $     0.33 $     0.55 $    (0.65)
  Loss from discontinued
   operations                          --         --         --      (0.01)
                               ---------- ---------- ---------- ----------
  Net income (loss)            $     0.25 $     0.33 $     0.55 $    (0.66)

Adjusted EBITDA (2)            $   14,503 $   13,291 $   28,100 $   24,840
                               ========== ========== ========== ==========
Adjusted EBITDAR (2)           $   19,614 $   18,284 $   38,294 $   34,763
                               ========== ========== ========== ==========

(1) Reflects the reclassification of the operations of 118 units previously
reported as continuing operations to discontinued operations.
(2) See attached tables for definitions of Adjusted EBITDA and Adjusted
EBITDAR and reconciliations of net income to Adjusted EBITDA and Adjusted
EBITDAR.




                   ASSISTED LIVING CONCEPTS, INC.
                    Consolidated Balance Sheets
           (In thousands, except share and per share data)

                                                  June 30,    December 31,
                                                    2010          2009
                                                ------------  ------------
                 ASSETS                          (unaudited)
Current Assets:
  Cash and cash equivalents                     $     12,239  $      4,360
  Investments                                          3,568         3,427
  Accounts receivable, less allowances of
   $1,096 and $738, respectively                       3,627         2,668
  Prepaid expenses, supplies and other
   receivables                                         4,095         3,537
  Deposits in escrow                                   1,763         1,993
  Income taxes receivable                                 --           723
  Deferred income taxes                                4,590         4,636
  Current assets of discontinued operations              168            36
                                                ------------  ------------
     Total current assets                             30,050        21,380
Property and equipment, net                          411,894       415,454
Intangible assets, net                                11,003        11,812
Restricted cash                                        3,017         4,389
Other assets                                           1,977         1,935
Non-current assets of discontinued operations             --           399
                                                ------------  ------------
    Total Assets                                $    457,941  $    455,369
                                                ============  ============

    LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
  Accounts payable                              $      5,749  $      8,005
  Accrued liabilities                                 16,177        19,228
  Deferred revenue                                     6,008         6,368
  Current maturities of long-term debt                 1,884         1,823
  Income tax payable                                   1,212            --
  Current portion of self-insured liabilities            500           500
  Current liabilities of discontinued
   operations                                             --            34
                                                ------------  ------------
     Total current liabilities                        31,530        35,958
Accrual for self-insured liabilities                   1,416         1,416
Long-term debt                                       118,954       119,914
Deferred income taxes                                 14,281        13,257
Other long-term liabilities                           11,801        11,853
Commitments and contingencies
                                                ------------  ------------
     Total Liabilities                               177,982       182,398
                                                ------------  ------------
Preferred Stock, par value $0.01 per share,
 25,000,000 shares authorized; no shares issued
 and outstanding                                          --            --
Class A Common Stock, $0.01 par value,
 80,000,000 shares authorized at June 30, 2010
 and December 31, 2009; 12,403,499 and
 12,397,525 shares issued and 10,108,938 and
 10,048,674 shares outstanding, respectively             124           124
Class B Common Stock, $0.01 par value,
 15,000,000 shares authorized at June 30, 2010
 and December 31, 2009; 1,523,085 and 1,528,650
 shares issued and outstanding, respectively              15            15
Additional paid-in capital                           314,964       314,602
Accumulated other comprehensive loss                    (775)       (2,012)
Retained earnings                                     39,995        33,486
Treasury stock at cost, 2,384,561 and 2,348,851
 shares, respectively                                (74,364)      (73,244)
                                                ------------  ------------
 Total Stockholders' Equity                          279,959       272,971
                                                ------------  ------------
Total Liabilities and Stockholders' Equity      $    457,941  $    455,369
                                                ============  ============



                  ASSISTED LIVING CONCEPTS, INC.
              Consolidated Statements of Cash Flows
                         (In thousands)
                          (unaudited)

                                                       Six Months Ended
                                                           June 30,
                                                     ---------------------
                                                        2010       2009
                                                     ---------- ----------
OPERATING ACTIVITIES:
Net income (loss)                                    $    6,509 $   (7,868)
Adjustments to reconcile net income (loss) to net
 cash provided by operating activities:
    Depreciation and amortization                        11,368     10,344
    Other-than-temporary investments impairment           2,026         --
    Goodwill impairment                                      --     16,315
    Amortization of purchase accounting adjustments
     for leases                                            (197)      (198)
    Provision for bad debts                                 358        (27)
    Provision for self-insured liabilities                  262        392
    Loss on disposal of fixed assets                        315         34
    Unrealized gain on investments                          (17)        --
    Equity-based compensation expense                       362        188
    Change in fair value of derivatives                      23         --
    Deferred income taxes                                   306       (154)
Changes in assets and liabilities:
    Accounts receivable                                  (1,317)       360
    Supplies, prepaid expenses and other receivables       (558)    (1,027)
    Deposits in escrow                                      230        388
    Current assets - discontinued operations               (132)        --
    Accounts payable                                     (1,432)    (1,735)
    Accrued liabilities                                  (3,051)      (231)
    Deferred revenue                                       (360)       424
    Current liabilities - discontinued operations           (34)        --
    Payments of self-insured liabilities                   (261)      (320)
    Income taxes payable / receivable                     1,935      4,296
    Changes in other non-current assets                   1,330        809
    Other non-current assets - discontinued
     operations                                             399         --
    Other long-term liabilities                             100        553
                                                     ---------- ----------
      Cash provided by operating activities              18,164     22,543
INVESTING ACTIVITIES:
    Payment for executive retirement plan securities       (110)       (95)
    Payments for new construction projects               (3,208)   (11,768)
    Payments for purchases of property and equipment     (4,930)    (6,930)
                                                     ---------- ----------
      Cash used in investing activities                  (8,248)   (18,793)
FINANCING ACTIVITIES:
    Purchase of treasury stock                           (1,120)    (4,860)
    Repayment of revolving credit facility                   --    (19,000)
  Proceeds from issuance of new mortgage debt                --     14,000
  Repayment of mortgage debt                               (917)    (8,114)
                                                     ---------- ----------
      Cash used by financing activities                  (2,037)   (17,974)
                                                     ---------- ----------
Increase (decrease) in cash and cash equivalents          7,879    (14,224)
Cash and cash equivalents, beginning of year              4,360     19,905
                                                     ---------- ----------
Cash and cash equivalents, end of period             $   12,239 $    5,681
                                                     ========== ==========
Supplemental schedule of cash flow information:
Cash paid during the period for:
  Interest                                           $    3,575 $    3,663
  Income tax payments, net of refunds                     1,494     (1,892)



                ASSISTED LIVING CONCEPTS, INC.
              Financial and Operating Statistics

Continuing residences*                           Three months ended
                                           -------------------------------
                                           June 30,   March 31,   June 30,
                                             2010       2010        2009
                                           ---------  ---------  ---------
Average Occupied Units by Payer Source
Private                                        5,476      5,468      5,354
Medicaid                                         162        214        445
                                           ---------  ---------  ---------
Total                                          5,638      5,682      5,799
                                           =========  =========  =========

Occupancy Mix by Payer Source
Private                                         97.1%      96.2%      92.3%
Medicaid                                         2.9%       3.8%       7.7%

Percent of Revenue by Payer Source
Private                                         98.1%      97.5%      95.0%
Medicaid                                         1.9%       2.5%       5.0%

Average Revenue per Occupied Unit Day      $  113.64  $  113.13  $  107.42

Occupancy Percentage*                           62.7%      63.0%      64.2%

* Depending on the timing of new additions and temporary closures of our
residences, we may increase or reduce the number of units we actively
operate. For the three months ended June 30, 2010, March 31, 2010 and June
30, 2009 we actively operated 8,991, 9,025 and 9,154 units, respectively.



Same residence basis**                           Three months ended
                                           -------------------------------
                                           June 30,   March 31,   June 30,
                                             2010       2010        2009
                                           ---------  ---------  ---------
Average Occupied Units by Payer Source
Private                                        5,417      5,423      5,304
Medicaid                                         162        210        387
                                           ---------  ---------  ---------
Total                                          5,579      5,633      5,691
                                           =========  =========  =========

Occupancy Mix by Payer Source
Private                                         97.1%      96.3%      93.2%
Medicaid                                         2.9%       3.7%       6.8%

Percent of Revenue by Payer Source
Private                                         98.1%      97.5%      95.6%
Medicaid                                         1.9%       2.5%       4.4%

Average Revenue per Occupied Unit Day      $  113.49  $  112.92  $  107.28

Occupancy Percentage                            63.4%      64.0%      64.6%

** Excludes quarterly impact of 111 completed expansion units and 76
re-opened renovated units.



                   ASSISTED LIVING CONCEPTS, INC.
                 Financial and Operating Statistics

Continuing residences*                                  Six months ended
                                                      --------------------
                                                       June 30,   June 30,
                                                        2010        2009

Average Occupied Units by Payer Source
Private                                                   5,472      5,369
Medicaid                                                    188        483
                                                      ---------  ---------
Total                                                     5,660      5,852
                                                      =========  =========

Occupancy Mix by Payer Source
Private                                                    96.7%      91.7%
Medicaid                                                    3.3%       8.3%

Percent of Revenue by Payer Source
Private                                                    97.8%      94.4%
Medicaid                                                    2.2%       5.6%

Average Revenue per Occupied Unit Day                 $  113.39  $  107.38

Occupancy Percentage*                                      62.9%      64.9%

* Depending on the timing of new additions and temporary closures of our
residences, we may increase or reduce the number of units we actively
operate. For the six months ended June 30, 2010 and June 30, 2009 we
actively operated 9,004 and 9,014 units, respectively.



Same residence basis**                                  Six months ended
                                                      -------------------
                                                       June 30,   June 30,
                                                        2010        2009

Average Occupied Units by Payer Source
Private                                                   5,392      5,327
Medicaid                                                    186        419
                                                      ---------  ---------
Total                                                     5,578      5,746
                                                      =========  =========

Occupancy Mix by Payer Source
Private                                                    96.7%      92.7%
Medicaid                                                    3.3%       7.3%

Percent of Revenue by Payer Source
Private                                                    97.8%      95.0%
Medicaid                                                    2.2%       5.0%

Average Revenue per Occupied Unit Day                 $  113.08  $  107.73

Occupancy Percentage                                       64.3%      66.3%

** Excludes quarterly impact of 245 completed expansion units, 39 units
temporarily closed for renovation and 76 re-opened renovated units.

Non-GAAP Financial Measures

Adjusted EBITDA and Adjusted EBITDAR

Adjusted EBITDA is defined as net income from continuing operations before
income taxes, interest expense net of interest income, depreciation and
amortization, equity based compensation expense, transaction costs and
non-cash, non-recurring gains and losses, including disposal of assets and
impairment of long-lived assets (including goodwill) and loss on
refinancing and retirement of debt. Adjusted EBITDAR is defined as
Adjusted EBITDA before rent expenses incurred for leased assisted living
properties. Adjusted EBITDA and Adjusted EBITDAR are not measures of
performance under accounting principles generally accepted in the United
States of America, or GAAP. We use Adjusted EBITDA and Adjusted EBITDAR as
key performance indicators and Adjusted EBITDA and Adjusted EBITDAR
expressed as a percentage of total revenues as a measurement of margin.

We understand that EBITDA and EBITDAR, or derivatives thereof, are
customarily used by lenders, financial and credit analysts, and many
investors as a performance measure in evaluating a company’s ability to
service debt and meet other payment obligations or as a common valuation
measurement in the long-term care industry. Moreover, ALC’s revolving
credit facility contains covenants in which a form of EBITDA is used as a
measure of compliance, and we anticipate EBITDA will be used in covenants
in any new financing arrangements that we may establish. We believe
Adjusted EBITDA and Adjusted EBITDAR provide meaningful supplemental
information regarding our core results because these measures exclude the
effects of non-operating factors related to our capital assets, such as the
historical cost of the assets.

We report specific line items separately, and exclude them from Adjusted
EBITDA and Adjusted EBITDAR because such items are transitional in nature
and would otherwise distort historical trends. In addition, we use
Adjusted EBITDA and Adjusted EBITDAR to assess our operating performance
and in making financing decisions. In particular, we use Adjusted EBITDA
and Adjusted EBITDAR in analyzing potential acquisitions and internal
expansion possibilities. Adjusted EBITDAR performance is also used in
determining compensation levels for our senior executives. Adjusted EBITDA
and Adjusted EBITDAR should not be considered in isolation or as a
substitute for net income, cash flows from operating activities, and other
income or cash flow statement data prepared in accordance with GAAP, or as
a measure of profitability or liquidity. We present Adjusted EBITDA and
Adjusted EBITDAR on a consistent basis from period to period, thereby,
allowing for comparability of operating performance.


Adjusted EBITDA and Adjusted EBITDAR Reconciliation Information

The following table sets forth a reconciliation of net income (loss) to
Adjusted EBITDA and Adjusted EBITDAR:

                              Three months ended         Six months ended
                          ----------------------------  ------------------
                          June 30,  June 30,  March 31, June 30,  June 30,
                            2010      2009      2010      2010      2009
                          --------  --------  --------  --------  --------
                                           (in thousands)
Net income (loss)         $  2,896  $  3,907  $  3,613  $  6,509    (7,868)
Less: Income (loss) from
 discontinued operations,
 net of tax                      -       (34)        -         -      (178)
Add: provision for income
 taxes                       1,618     2,182     2,123     3,741     2,326
                          --------  --------  --------  --------  --------

Income (loss) from
 continuing operations
 before income taxes      $  4,514  $  6,123  $  5,736    10,250    (5,364)
Add:
  Depreciation and
   amortization              5,698     5,218     5,670    11,368    10,149
  Interest expense, net      1,895     1,827     1,884     3,779     3,518
  Non-cash equity based
   compensation                225       123       137       362       188
  Loss on disposal of
   fixed assets                145         -       170       315        34
  Write-down of equity
   investments               2,026         -         -     2,026
  Goodwill impairment            -         -         -         -    16,315
                          --------  --------  --------  --------  --------

Adjusted EBITDA             14,503    13,291    13,597    28,100    24,840
Add: Lease expense           5,111     4,993     5,083    10,194     9,923
                          --------  --------  --------  --------  --------
Adjusted EBITDAR          $ 19,614  $ 18,284  $ 18,680  $ 38,294  $ 34,763
                          ========  ========  ========  ========  ========

Adjusted EBITDA             14,503    13,291    13,597    28,100    24,840
Add: Division realignment
 expense                       453         -         -       453         -
                          --------  --------  --------  --------  --------
Adjusted EBITDA before
 division realignment
 expense                    14,956    13,291    13,597    28,553    24,840
Add: Lease expense           5,111     4,993     5,083    10,194     9,923
                          --------  --------  --------  --------  --------
Adjusted EBITDAR before
 division realignment
 expense                  $ 20,067  $ 18,284  $ 18,680  $ 38,747  $ 34,763
                          ========  ========  ========  ========  ========

The following table sets forth the calculations of Adjusted EBITDA,
Adjusted EBITDAR, Adjusted EBITDA before division realignment and Adjusted
EBITDAR before division realignment as percentages of total revenue:

                           Three months ended           Six months ended
                     -------------------------------  --------------------
                     June 30,   June 30,   March 31,  June 30,   June 30,
                      2010(1)     2009       2010      2010(1)     2009
                     ---------  ---------  ---------  ---------  ---------
                                         (in thousands)
Revenues             $  58,305  $  56,683  $  57,859  $ 116,164  $ 113,750
                     =========  =========  =========  =========  =========

Adjusted EBITDA      $  14,503  $  13,291  $  13,597  $  28,100  $  24,840
                     =========  =========  =========  =========  =========

Adjusted EBITDAR     $  19,614  $  18,284  $  18,680  $  38,294  $  34,763
                     =========  =========  =========  =========  =========

Adjusted EBITDA as
 percent of total
 revenues                 24.9%      23.4%      23.5%      24.2%      21.8%
                     =========  =========  =========  =========  =========

Adjusted EBITDAR as
 percent of total
 revenues                 33.6%      32.3%      32.3%      33.0%      30.6%
                     =========  =========  =========  =========  =========


     (1) Includes division realignment expenses of $453 in both the
     quarter and six months ended June 30, 2010. Excluding division
     realignment expenses,  Adjusted EBITDA, Adjusted EBITDAR, Adjusted
     EBITDA as a percent of sales and Adjusted EBITDAR as a percent of
     sales for the quarter ended June 30, 2010 would have been $14,956,
     $20,067, 25.7% and 34.4%, respectively.   Adjusted EBITDA, Adjusted
     EBITDAR, Adjusted EBITDA as a percent of sales and Adjusted EBITDAR as
     a percent of sales for the six months ended June 30, 2010 would have
     been $28,553, $38,747, 24.6% and 33.4%, respectively.




                     ASSISTED LIVING CONCEPTS, INC.
                  Reconciliation of Non-GAAP Measures
                              (unaudited)


                                             Three       Six        Six
                                             Months     Months     Months
                                             Ended      Ended      Ended
                                            June 30,   June 30,   June 30,
                                             2010       2010       2009
                                             (dollars in thousands except
                                                   per share data)
Net income (loss)                          $   2,896  $   6,509  $  (7,868)
Add: Loss from discontinued operations,
 net of tax                                        -          -        178
                                           ---------  ---------  ---------
Income (loss) from continuing operations       2,896      6,509     (7,690)
                                           ---------  ---------  ---------
Add one time charge:
  Write down of equity investments             2,026      2,026          -
  Goodwill impairment                              -          -     16,315
  Loss on disposal of fixed assets related
   to expansion project                          125        125          -
Division realignment expense                     453        453          -
Less: Income tax benefits from one-time
 charges                                         933        933      1,622
                                           ---------  ---------  ---------
  Pro forma net income from continuing
   operations excluding one-time charges   $   4,567  $   8,180  $   7,003
                                           =========  =========  =========

Weighted average common shares:
Basic                                         11,567     11,572     11,882
Diluted                                       11,738     11,741     11,882

Per share data:
  Basic earnings per common share
  Income (loss) from continuing operations $    0.25  $    0.56  $   (0.65)
  Less: loss from discontinued operations          -          -      (0.01)
  Less: loss from one-time charges             (0.14)     (0.14)     (1.24)
                                           ---------  ---------  ---------
  Pro forma net income from continuing
   operations excluding one-time charges   $    0.39  $    0.70  $    0.60
                                           =========  =========  =========

  Diluted earnings per common share*
  Income (loss) from continuing operations $    0.25  $    0.55  $   (0.65)
  Less: loss from discontinued operations          -          -      (0.01)
  Less: loss from one-time charges             (0.14)     (0.14)     (1.24)
                                           ---------  ---------  ---------
  Pro forma net income from continuing
   operations excluding one-time charges   $    0.39  $    0.70  $    0.60
                                           =========  =========  =========

* Per share numbers may not add due to rounding

Filed Under: Facilities And Providers

Myomo Launches myomo@home Program

Posted on August 9, 2010 Written by Annalyn Frame

SOURCE: Myomo

CAMBRIDGE, MA–(Marketwire – August 9, 2010) –  Myomo, Inc., the developer of neuro-robotic stroke rehabilitation technology, has launched myomo@home, a program that enables stroke survivors to purchase the Myomo System directly for use at home. The system is a neuro-robotic rehabilitation device that helps impaired stroke survivors increase movement in their arms, and has been clinically proven effective from two days to 21 years post stroke. Used in the clinical setting since 2008, the Myomo System is now available directly to consumers with a physician’s prescription. Myomo has successfully completed FDA requirements to demonstrate that the device is safe for use in the home.

“Our goal is to make the Myomo System available to as many people as can benefit from it,” explains Steve Kelly, Myomo’s CEO. “Stroke is the leading cause of disability in the US. There is a great need to restore independence to those who have suffered a stroke. Our new program expands access to world-class rehabilitation therapy and technology to any individual at home regardless of geography.”

“We were able to get therapy with the Myomo System, but the nearest clinic was a four hour round trip drive,” said Dean Kenefick, who suffered a stroke in 2004. “When Myomo started a pilot program for home use, we purchased one. I use the Myomo device three times a week and consistently get more return of muscle and movement.”

A Model for Delivering High-Frequency Stroke Rehabilitation

myomo@home is a comprehensive program that leverages evidence-based techniques to restore arm movement. It combines the Myomo System with therapy from a trained and certified Myomo physical or occupational therapist. Direction from a therapist and adherence to a prescribed protocol is critical to the success of stroke patients using the Myomo System at home. 

“Myomo was developed based on a well-known principle that if you work at it, you will get better at it,” said Steve Williams, MD, Chief, Chairman, Department of Rehabilitation Medicine at Boston Medical Center. “Just like learning and getting better at a sport or a craft, re-learning to move your arm requires repetitive practice to keep getting better at it.”

To acquire the product, Myomo has a defined process that includes an in-person or a Web-based video screening and the participation of a clinical partner or a local therapist. If the patient doesn’t have access to a local therapy resource, Myomo works with them to connect with a local therapist through its independent therapist network. 

Myomo provides therapist training and certification through a multi-level certification program that is completed either in-person or live via the Web. Each therapy protocol is customized for the individual patient and follow-up is conducted to adjust treatment for the most potential improvement. Unlimited phone customer service is included with the program.

About Myomo

Myomo develops neuro-robotic technology that helps impaired stroke survivors regain movement in their arms. The company combines technology developed at Massachusetts Institute of Technology (MIT), with rehabilitation professionals trained at the best hospitals in the country, to help stroke patients regain independence. For more information, visit www.myomo.com. Join us on Facebook at http://www.facebook.com/pages/Cambridge-MA/Myomo/196353791770.

CONTACT:
Matt Burke
Email Contact
US +1 603.315.0618

Filed Under: Facilities And Providers

Correction: Vigil Health Solutions Reports Q1 Results, Sales Bookings Up 26%

Posted on August 9, 2010 Written by Annalyn Frame

VICTORIA, BRITISH COLUMBIA–(Marketwire – Aug. 9, 2010) –Marketwire would like to issue a correction for the press release issued at 12:30 PM ET. The URL for Vigil’s Financial Statements contained incorrect HTML coding. The proper link is http://www.vigil.com/?Investors:Financial_Statements. The corrected release follows:

 Vigil Health Solutions Inc. (TSX VENTURE:VGL) (“Vigil”) announces the results of operations for the quarter ending June 30, 2010.

Business highlights

  • Grew bookings 26% for the quarter to $955 thousand compared to $755 thousand for the three-month period ended June 30, 2009.
  • Increased backlog 14% to approximately $3.1 million compared to approximately $2.72 million at June 30, 2009.
  • Revenue was $641 thousand for the three-months ended June 30, 2010 compared to $1.37 million in the three-month period ended June 30, 2009, a decrease of 53%. The decrease reflects lower bookings in FYE2010 and the timing in projects commissioned.
  • Expanded revenue from service and maintenance agreements and one-off sales by 72% during the quarter ended June 30, 2010 to $298 thousand.

“I am encouraged with our increased sales bookings which I believe is a positive indication of both the improvement in the economy, as well as our continued investment in sales and marketing,” stated Troy Griffiths, President and CEO of Vigil Health Solutions Inc.

Financial Results

Revenue for the three-months ended June 30, 2010 was $641 thousand compared to $1.37 million in the three-month period ended June 30, 2009, a decrease of 53%. The decrease in revenue reflects both the reduced number and size of the projects completed during the quarter. Because Vigil records revenue using the completed contract method the number of projects completed this quarter directly reflects a lag related to the timing of the US economic downturn.

Bookings for the quarter were $955 thousand up 26% compared to $755 thousand in the three-month period ended June 30, 2009. The increase in bookings relates to an improvement in the United States economy, specifically, in funding availability for new construction in the seniors living industry as well as the Company’s investment in it sales program.

At June 30, 2010, Vigil had a backlog of approximately $3.1 million (including $1.64 million in deposits and progress billings, recorded as deferred revenue on the balance sheet) a 14% increase compared to approximately $2.72 million (including $1.34 million in deposits and progress billings, recorded as deferred revenue on the balance sheet) at June 30, 2009. This increase is the result of booking more new projects than recorded as revenue during the quarter.

The gross margin percentage for the three months ended June 30, 2010 was 45% compared to 48% for the three months ended June 30, 2009. The gross margin during the period was with in management’s expectations of margins of between 42% and 47%.

Expenditures for the three months ended June 30, 2010 were $465 thousand down 22% from operating expenditures of $599 thousand for the same period ended June 30, 2009. The Company decreased expenditures in all areas. These decreases were the result of a combined strategic effort to focus resources where they would be best utilized.

Net loss for the three month period ended June 30, 2010 was $180 thousand, or $0.002 per share compared to a gain of $66 thousand, or $0.001 per share for the previous year. The increase in losses is primarily attributable to the lower in revenue in the period.

Detailed financial statements along with Management Discussion and Analysis have been filed with SEDAR and may be viewed on the Company web site (http://www.vigil.com/?Investors:Financial_Statements) or at (www.sedar.com).

Financial information will be mailed to entitled security holders on August 16, 2010. Or, upon notice to the Company, entitled security holders may request a copy of financials in advance.

Summary Financial Information

  June 30, June 30,
  2010 2009
  (unaudited) (unaudited)
     
Revenue $641,420 $1,370,157
Cost of sales 355,705 708,450
  285,715 661,707
     
Expenses 472,943 612,120
     
Income before the following items (187,228) 49,587
     
Other income (expense): 6,983 16,181
     
Income / (loss) for the period $(180,245) $65,768

Non-GAAP Measure

For the three months ended June 30, 2010, we are disclosing Adjusted EBITDA, a non-GAAP financial measure, as a supplementary indicator of operating performance. We define Adjusted EBITDA as net income before, interest, income taxes, amortization, stock based compensation and currency gains or losses including derivative foreign exchange differences. We are presenting the non-GAAP financial measure in our filings because we use it internally to make strategic decisions, forecast future results and to evaluate our performance and because we believe that our current and potential investors and analysts use the measure to assess current and future operating results and to make investment decisions. It is a non-GAAP measure, may not be comparable to other companies and it is not intended as a substitute for GAAP measures.

Adjusted EBITDA reconciliation

  Three months ended
  June 30, 2010 June 30, 2009
     
Income / (loss) for the period $(180,245) $65,768
     
  Add / (deduct)    
  Foreign exchange gain (loss) 15,382 (40,477)
  Derivative exchange gain (7,883) 55,212
  Interest (516) 1,446
  Stock based compensation (10,423) (1,280)
  Amortization (7,825) (12,982)
  (11,265) 1,919
     
Adjusted EBITDA $(168,980) $63,849

About Vigil Health Solutions Inc.

Vigil offers a proprietary technology platform combining software and hardware to provide comprehensive solutions to the expanding seniors’ housing market. Vigil has established a growing presence in North America and an international reputation for being on the leading edge of systems design and integration. The Vigil Integrated Care Management System™ (Vigil® System) includes the award-winning Vigil Dementia System, a nurse call system, bed monitoring, resident check in, and the latest development the Vigil Wireless call system. The first to supply dementia specific care technology, Vigil facilitates the highest standard of care for cognitive residents while helping dementia residents enjoy a higher quality of life and greater dignity.

Certain statements contained in this news release that are not based on historical facts may constitute forward-looking statements or forward-looking information within the meaning of applicable securities laws (“forward-looking statements”). These forward-looking statements are not promises or guarantees of future performance but are only predictions that relate to future events, conditions or circumstances or our future results, performance, achievements or developments and are subject to substantial known and unknown risks, assumptions, uncertainties and other factors that could cause our actual results, performance, achievements or developments in our business or in our industry to differ materially from those expressed, anticipated or implied by such forward-looking statements.

Forward-looking statements include all financial guidance, disclosure regarding possible events, conditions, circumstances or results of operations that are based on assumptions about future economic conditions, courses of action and other future events. We caution you not to place undue reliance upon any such forward-looking statements, which speak only as of the date they are made. These forward-looking statements appear in a number of different places in this presentation and can be identified by words such as “may”, “estimates”, “projects”, “expects”, “intends”, “believes”, “plans”, “anticipates”, or their negatives or other comparable words. Forward-looking statements include statements regarding the outlook for our future operations, plans and timing for the introduction or enhancement of our services and products, statements concerning strategies or developments, statements about future market conditions, supply conditions, end customer demand conditions, channel inventory and sell through, revenue, gross margin, operating expenses, profits, forecasts of future costs and expenditures, the outcome of legal proceedings, and other expectations, intentions and plans that are not historical fact.

The risk factors and uncertainties that may affect our actual results, performance, achievements or developments are many and include, amongst others, our ability to develop our sales force and generate revenue, the length of the sales cycle, management of the Company’s growth, ability to recruit and retain staff, fluctuations in demand for current and future products, our ability to develop, manufacture, supply and market existing and new products that meet the needs of customers, volatility in the exchange rate, ability to secure financing, ability to secure product liability insurance, the continuous commitment of our customers, increased competition, changes in regulation and reliance on third party suppliers. These risk factors and others are discussed in the Risks and Uncertainties section of our “Management Discussion and Analysis” segment of our fiscal 2009 Annual Report. Many of these factors and uncertainties are beyond the control of the Company. Consequently, all forward-looking statements in this news release are qualified by this cautionary statement and there can be no assurance that actual results, performance, achievements or developments anticipated by the Company will be realized.

Forward-looking statements are based on management’s current plans, estimates, projections, beliefs and opinions and, except as required by law, the Company does not undertake any obligation to update forward-looking statements should the assumptions related to these plans, estimates, projections, beliefs and opinions change.

Filed Under: Facilities And Providers

Vigil Health Solutions Reports Q1 Results, Sales Bookings Up 26%

Posted on August 9, 2010 Written by Annalyn Frame

VICTORIA, BRITISH COLUMBIA–(Marketwire – Aug. 9, 2010) – Vigil Health Solutions Inc. (TSX VENTURE:VGL) (“Vigil”) announces the results of operations for the quarter ending June 30, 2010.

Business highlights

  • Grew bookings 26% for the quarter to $955 thousand compared to $755 thousand for the three-month period ended June 30, 2009.
  • Increased backlog 14% to approximately $3.1 million compared to approximately $2.72 million at June 30, 2009.
  • Revenue was $641 thousand for the three-months ended June 30, 2010 compared to $1.37 million in the three-month period ended June 30, 2009, a decrease of 53%. The decrease reflects lower bookings in FYE2010 and the timing in projects commissioned.
  • Expanded revenue from service and maintenance agreements and one-off sales by 72% during the quarter ended June 30, 2010 to $298 thousand.

“I am encouraged with our increased sales bookings which I believe is a positive indication of both the improvement in the economy, as well as our continued investment in sales and marketing,” stated Troy Griffiths, President and CEO of Vigil Health Solutions Inc.

Financial Results

Revenue for the three-months ended June 30, 2010 was $641 thousand compared to $1.37 million in the three-month period ended June 30, 2009, a decrease of 53%. The decrease in revenue reflects both the reduced number and size of the projects completed during the quarter. Because Vigil records revenue using the completed contract method the number of projects completed this quarter directly reflects a lag related to the timing of the US economic downturn.

Bookings for the quarter were $955 thousand up 26% compared to $755 thousand in the three-month period ended June 30, 2009. The increase in bookings relates to an improvement in the United States economy, specifically, in funding availability for new construction in the seniors living industry as well as the Company’s investment in it sales program.

At June 30, 2010, Vigil had a backlog of approximately $3.1 million (including $1.64 million in deposits and progress billings, recorded as deferred revenue on the balance sheet) a 14% increase compared to approximately $2.72 million (including $1.34 million in deposits and progress billings, recorded as deferred revenue on the balance sheet) at June 30, 2009. This increase is the result of booking more new projects than recorded as revenue during the quarter.

The gross margin percentage for the three months ended June 30, 2010 was 45% compared to 48% for the three months ended June 30, 2009. The gross margin during the period was with in management’s expectations of margins of between 42% and 47%.

Expenditures for the three months ended June 30, 2010 were $465 thousand down 22% from operating expenditures of $599 thousand for the same period ended June 30, 2009. The Company decreased expenditures in all areas. These decreases were the result of a combined strategic effort to focus resources where they would be best utilized.

Net loss for the three month period ended June 30, 2010 was $180 thousand, or $0.002 per share compared to a gain of $66 thousand, or $0.001 per share for the previous year. The increase in losses is primarily attributable to the lower in revenue in the period.

Detailed financial statements along with Management Discussion and Analysis have been filed with SEDAR and may be viewed on the Company web site (http://www.vigil.com/?Investors:Financial_Statements) or at (www.sedar.com).

Financial information will be mailed to entitled security holders on August 16, 2010. Or, upon notice to the Company, entitled security holders may request a copy of financials in advance.

Summary Financial Information

  June 30, June 30,
  2010 2009
  (unaudited) (unaudited)
     
Revenue $641,420 $1,370,157
Cost of sales 355,705 708,450
  285,715 661,707
     
Expenses 472,943 612,120
     
Income before the following items (187,228) 49,587
     
Other income (expense): 6,983 16,181
     
Income / (loss) for the period $(180,245) $65,768

Non-GAAP Measure

For the three months ended June 30, 2010, we are disclosing Adjusted EBITDA, a non-GAAP financial measure, as a supplementary indicator of operating performance. We define Adjusted EBITDA as net income before, interest, income taxes, amortization, stock based compensation and currency gains or losses including derivative foreign exchange differences. We are presenting the non-GAAP financial measure in our filings because we use it internally to make strategic decisions, forecast future results and to evaluate our performance and because we believe that our current and potential investors and analysts use the measure to assess current and future operating results and to make investment decisions. It is a non-GAAP measure, may not be comparable to other companies and it is not intended as a substitute for GAAP measures.

Adjusted EBITDA reconciliation

  Three months ended
  June 30, 2010 June 30, 2009
     
Income / (loss) for the period $(180,245) $65,768
     
  Add / (deduct)    
  Foreign exchange gain (loss) 15,382 (40,477)
  Derivative exchange gain (7,883) 55,212
  Interest (516) 1,446
  Stock based compensation (10,423) (1,280)
  Amortization (7,825) (12,982)
  (11,265) 1,919
     
Adjusted EBITDA $(168,980) $63,849

About Vigil Health Solutions Inc.

Vigil offers a proprietary technology platform combining software and hardware to provide comprehensive solutions to the expanding seniors’ housing market. Vigil has established a growing presence in North America and an international reputation for being on the leading edge of systems design and integration. The Vigil Integrated Care Management System™ (Vigil® System) includes the award-winning Vigil Dementia System, a nurse call system, bed monitoring, resident check in, and the latest development the Vigil Wireless call system. The first to supply dementia specific care technology, Vigil facilitates the highest standard of care for cognitive residents while helping dementia residents enjoy a higher quality of life and greater dignity.

Certain statements contained in this news release that are not based on historical facts may constitute forward-looking statements or forward-looking information within the meaning of applicable securities laws (“forward-looking statements”). These forward-looking statements are not promises or guarantees of future performance but are only predictions that relate to future events, conditions or circumstances or our future results, performance, achievements or developments and are subject to substantial known and unknown risks, assumptions, uncertainties and other factors that could cause our actual results, performance, achievements or developments in our business or in our industry to differ materially from those expressed, anticipated or implied by such forward-looking statements.

Forward-looking statements include all financial guidance, disclosure regarding possible events, conditions, circumstances or results of operations that are based on assumptions about future economic conditions, courses of action and other future events. We caution you not to place undue reliance upon any such forward-looking statements, which speak only as of the date they are made. These forward-looking statements appear in a number of different places in this presentation and can be identified by words such as “may”, “estimates”, “projects”, “expects”, “intends”, “believes”, “plans”, “anticipates”, or their negatives or other comparable words. Forward-looking statements include statements regarding the outlook for our future operations, plans and timing for the introduction or enhancement of our services and products, statements concerning strategies or developments, statements about future market conditions, supply conditions, end customer demand conditions, channel inventory and sell through, revenue, gross margin, operating expenses, profits, forecasts of future costs and expenditures, the outcome of legal proceedings, and other expectations, intentions and plans that are not historical fact.

The risk factors and uncertainties that may affect our actual results, performance, achievements or developments are many and include, amongst others, our ability to develop our sales force and generate revenue, the length of the sales cycle, management of the Company’s growth, ability to recruit and retain staff, fluctuations in demand for current and future products, our ability to develop, manufacture, supply and market existing and new products that meet the needs of customers, volatility in the exchange rate, ability to secure financing, ability to secure product liability insurance, the continuous commitment of our customers, increased competition, changes in regulation and reliance on third party suppliers. These risk factors and others are discussed in the Risks and Uncertainties section of our “Management Discussion and Analysis” segment of our fiscal 2009 Annual Report. Many of these factors and uncertainties are beyond the control of the Company. Consequently, all forward-looking statements in this news release are qualified by this cautionary statement and there can be no assurance that actual results, performance, achievements or developments anticipated by the Company will be realized.

Forward-looking statements are based on management’s current plans, estimates, projections, beliefs and opinions and, except as required by law, the Company does not undertake any obligation to update forward-looking statements should the assumptions related to these plans, estimates, projections, beliefs and opinions change.

Filed Under: Facilities And Providers

Sandhills Pediatrics Selects the SRS Hybrid EMR for Its 14 Providers and 4 Locations

Posted on August 9, 2010 Written by Annalyn Frame

SOURCE: SRSsoft

Comparative Benchmarking Confirmed Productivity and Physician Focus of SRS Hybrid EMR

MONTVALE, NJ–(Marketwire – August 9, 2010) –  SRS, the leader in high-performance hybrid EMRs, today announced that Sandhills Pediatrics has selected the SRS hybrid EMR for its 14 providers. Sandhills Pediatrics has four offices in the greater Columbia, South Carolina, area and has served the community’s families since 1975.

“I see 38-45 patients a day, so I wanted an EMR that would easily adapt to my workflow and not hinder the pace of my schedule,” says Kevin O. Wessinger, M.D., Sandhills Pediatrics. “The SRS hybrid EMR allows me to practice the way I like, while eliminating the gross inefficiencies of a paper-centric office. Implementation was smooth — we didn’t have to compromise our productivity at all, even during the first few days!”

“The stopwatch doesn’t lie. During our EMR selection process, we looked at several traditional, point-and-click systems and a free online EMR,” says Ken Fenchel, Practice Administrator, Sandhills Pediatrics. “We timed how long it takes to perform common workflow tasks with each EMR and realized that SRS is the easiest and fastest by far. The higher level of productivity is critical to our physicians’ ability to provide quality care to our high volume of patients.”

SRS was designed with direct input by its high-performance physicians to provide them with a system that fits their needs, helps them to work more efficiently, and enables them to achieve a rapid return on their investment. SRS, which has built the largest national network of high-performance practices that successfully use an EMR, attributes its unmatched adoption rate to ease of use, fast implementation, and an accelerated timeframe for training physicians and office staff.

“If more practices took the time to do comparative benchmarking, the rate of successful EMR adoptions would increase,” says Evan Steele, CEO of SRSsoft. “We are confident that Sandhills — like our other pediatric practice clients — will see immediate and ongoing benefits with SRS throughout their offices, and we are very happy to have them join our growing national network of 5,000 providers.”

About Sandhills Pediatrics
Sandhills Pediatrics has a long and distinguished history of caring for children. Established in 1975 by Dr. S. Nelson Weston and Dr. Charles A. James, Sandhills offers comprehensive and well-rounded medical services to children from birth through college age. Visit www.sandhillsped.com for more information.

About SRS
For over a decade, SRS has been the leading provider of productivity-enhancing EMR technology — with a successful adoption rate unparalleled in the industry. The robust SRS hybrid EMR increases physicians’ speed and practice revenue by offering powerful and flexible solutions that streamline clinical workflows and enhance patient care. Prominent pediatric groups choose SRS because of its fit with the demands of their specialty. For more information on SRS, visit www.srssoft.com, e-mail [email protected], fax 201.802.1301, or call 800.288.8369.

Media Contact
Jeremy Duca
SRSsoft
800.288.8369
Email Contact

Filed Under: Facilities And Providers

Sage Healthcare Division Supports National Health Center Week for 4th Consecutive Year

Posted on August 9, 2010 Written by Annalyn Frame

SOURCE: Sage

Employees Volunteer Time at Community Health Centers Across the U.S.

TAMPA, FL–(Marketwire – August 9, 2010) –  Sage North America today announced that Sage Healthcare Division, a leading provider of electronic health record (EHR) and practice management software, is showing its support for National Health Center Week (August 8 – 14, 2010) by offering volunteer assistance at community health centers across the country during the week through its ProjectSERVS (Sage Employees Reaching out with Volunteer Service).

National Health Center Week is an annual celebration designed to raise awareness about the valuable work that community health centers do. During this week, health centers across the country host events to educate people on healthcare and the types of services provided by the centers. Many events feature free health screenings, food and refreshments, prominent speakers, and more.

“National Health Center Week is a tremendous opportunity to highlight the vital role health centers play in their community. We are appreciative of Sage’s support to make the week even more successful for health centers across the country,” said Dan Hawkins, Senior Vice-President of Policy and Research at the National Association of Community Health Centers. “Sage’s efforts are helping to strengthen health centers in numerous communities, and we stand ready to work with everyone in the years ahead to make sure all people have a healthcare home at a community health center.”

Sage Healthcare Division has supported the event for four consecutive years. This year, Sage employees are volunteering their time at several health centers across the U.S., including:

  • Health Linc in Michigan City, Indiana; Knox, Indiana; and Valparaiso, Indiana – Sage employees will host a back-to-school fair and carnival in which each clinic will provide free sports physicals, immunizations, school backpacks stuffed with supplies and lunch will be served at each site; and
  • New Hanover Health Center in Wilmington, North Carolina – Sage employees will be scanning paper medical records into the clinic’s electronic system.

“Sage continues to dedicate itself to furthering the mission of improving patient outcomes and quality of care in the United States. Our involvement with National Association of Community Health Centers’ National Health Center Week proves our commitment to this goal,” said Lee Horner, Senior Vice President of Sales for Sage Healthcare Division. “Sage strives to continuously serve communities through programs where Sage employees volunteer countless hours and thousands of dollars to support worthy causes every year, including community health centers, which we salute for the important role they play in our healthcare system.”

Sage has been a longstanding provider of information technology solutions to the CHC and Federally Qualified Health Center (FQHC) market, said Tony Ryzinski, Senior Vice President of Marketing for Sage Healthcare Division, and maintains a strong commitment to this segment by developing products that address its unique needs. 

“We maintain a close relationship with our CHC partners and continually solicit their input and recommendations,” Ryzinski said. “Many of our CHC partners provide critical insight into the needs of their clinics, providers and patients, and Sage recognizes the increasingly important role of the CHC and FQHC in today’s evolving healthcare economy, as their mission broadens in providing access to care to broader segments of the population.”

View Sage Healthcare Division YouTube interviews.
View Sage Healthcare Division information.

About Sage Healthcare Division
Sage Healthcare Division provides integrated electronic health records, EDI applications and practice management systems to more than 80,000 physicians and thousands of ambulatory care practices throughout North America. These systems enable physicians and practice managers to better manage their practices and improve profitability. Sage Healthcare Division is based in Tampa, Fla., and is a division of Sage North America. For more information, please visit www.sagehealth.com or call (877) 932-6301.

About Sage North America
Sage North America is part of The Sage Group plc, a leading global supplier of business management software and services. Sage North America employs 4,000 people and supports 3.1 million small and midsized business customers including more than 80,000 physicians. The Sage Group plc, formed in 1981, was floated on the London Stock Exchange in 1989 and now employs 13,100 people and supports 6.2 million customers worldwide. For more information, please visit the website at www.sagenorthamerica.com.

© 2010 Sage Software, Inc. All rights reserved. Sage, the Sage logos, and the Sage product and service names mentioned herein are registered trademarks or trademarks of Sage Software, Inc. or its affiliated entities. All other trademarks are the property of their respective owners.

Media Contact:
Scott Rupp
Sage North America
813-249-4264
[email protected]

Filed Under: Facilities And Providers

St Andrew’s Healthcare Turns to Imprivata to Simplify and Secure Access to Patient Data

Posted on August 9, 2010 Written by Annalyn Frame

SOURCE: Imprivata

OneSign Controls and Monitors Access to Patient Records While Improving User Workflows

LEXINGTON, MA–(Marketwire – August 9, 2010) –  Imprivata®, Inc., the company that simplifies and secures user access, today announced that St Andrew’s Healthcare, the UK’s largest not-for-profit mental health charity, has selected Imprivata OneSign to provide 3,500 employees with faster and more efficient access to a range of applications via single sign-on (SSO) and strong authentication with smart cards. The rollout, completed in June 2010 across the organisation’s four sites in Basildon, Birmingham, Mansfield and Northampton will allow clinical and support staff to increase the speed at which they can securely access patient information and raise the levels of patient care.

The implementation of OneSign will improve clinical productivity by providing users with a single point of secure access though which they can connect to multiple applications, including electronic patient records, HR, Finance, a range of intranet-based applications and its in-house knowledge system.

With OneSign St Andrew’s will bolster the levels of security around user access management without compromising productivity or patient care. OneSign will also ensure IT staff can quickly and efficiently audit access to patient information, helping to avoid malpractice by uncovering instances of shared passwords. This is especially valuable with increasingly strict compliance regulations around the issue of psychiatric medicines and drugs.

St Andrew’s is regularly audited by the Care Quality Commission and the Department of Health, who assess the standards of care being provided at healthcare organisations across the UK. As part of the process, auditors request access to random patient records and other data to ensure these are being managed securely. Previously, auditing employee access to patient data would involve manual printing of SQL tables, however with OneSign IT staff can access records at the click of a switch, simplifying compliance reporting.

“The nature of our work within mental health organisations involves both sensitive patient data and the prescription of psychiatric drugs — which underscores the importance of having complete control of who accesses our IT systems without jeopardising the productivity of our staff,” said Paul Kirkpatrick, Director of IT. “Working with Imprivata to implement single sign-on and strong authentication has enabled us to ensure that only authorised employees can access patient information and applications whilst also making sure we can improve the efficiency of our auditing for regulatory bodies.” 

Additionally, as a 24-hour psychiatric hospital, St Andrew’s has to ensure that medical staff can access data and applications round-the-clock and the self-service password reset module within OneSign will help reduce some of the 400 password reset calls to the IT helpdesk per month, freeing up one full-time employee for other activities.

“Patient data security is one of the primary IT concerns within the healthcare sector today, but not at the expense of employee productivity or patient safety,” said Omar Hussain, CEO and President, Imprivata. “Imprivata OneSign has long been a trusted name for both the NHS and private healthcare institutions across the globe, and we look forward to helping St Andrew’s simplify and secure access to patient data, improve workflow and ultimately the level of care delivered by its staff.”

About Imprivata
Imprivata is the leading independent vendor focused on simplifying and securing user access. By strengthening user authentication, streamlining application access and simplifying compliance reporting across multiple computing environments, customers can align security with user workflows and realize substantial productivity gains while lowering IT costs.

Imprivata has received numerous product awards and top review ratings from leading industry publications and analysts. Headquartered in Lexington, Mass., Imprivata partners with over 200 resellers, and serves the access security needs of more than 1,000 customers around the world. For more information, please visit www.imprivata.com.

Imprivata is a registered trademark of Imprivata, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.

RSS Feed to Imprivata News: http://feeds.feedburner.com/ImprivataNews

Follow Imprivata on Twitter: https://twitter.com/Imprivata

Contact:
Whitney Carbone
617-758-4177
Email Contact

id=”nav_links”>

Filed Under: Facilities And Providers

Indianapolis’ iSALUS Healthcare Chosen as Electronic Medical Records Preferred Software Partner for Indiana Health Information Technology Extension…

Posted on August 9, 2010 Written by Annalyn Frame

SOURCE: iSALUS Healthcare

INDIANAPOLIS, IN–(Marketwire – August 9, 2010) – Indianapolis-headquartered iSALUS Healthcare was recently selected by Indiana Health Information Technology Extension Center (I-HITEC), as a collaborative statewide initiative led by Purdue University, as an electronic medical records (EMR) preferred software partner. This partnership and endorsement allows iSALUS to serve Indiana’s healthcare community as part of a federal stimulus program to implement EMR software systems.

“The entire team at iSALUS has a vested and personal interest in being chosen as a preferred software provider,” said Michael Hall, president and founder of iSALUS Healthcare. “These are the doctors we trust to take care of our families, and we are honored to be chosen to help them provide the very best care to all of their patients.”

iSALUS was selected by I-HITEC from among hundreds of EMR software firms. The company was chosen based on its ability to assist healthcare providers in implementing electronic medical records, allowing them to qualify for federal stimulus money, a proven technology platform, previous experience with small to medium size healthcare practices, ability to quickly and efficiently implement a large number of new providers, and affordable pricing. Through this partnership, iSALUS and I-HITEC will provide Indiana healthcare providers with a full electronic medical records solution, education, training, implementation, technical and customer support.

“The Indiana Health Information Technology Extension Center is tasked with helping 2,200 Indiana primary care providers (PCPs) achieve Meaningful Use of electronic health record technology by 2012,” said Monica Arrowsmith, I-HITEC’s director. “We are confident we can reach this ambitious goal in partnership with iSALUS Healthcare as one of our certified EMR software partners. Together we will bring understandable, implementable and affordable EMR solutions to Indiana’s healthcare community.”

About iSALUS Healthcare
Founded in 2000 and headquartered in Indianapolis, iSALUS Healthcare offers web-based, mobile-optimized EMR and practice management software solutions for small to medium sized physician practices, healthcare offices and medical clinics. Its proven suite of easy-to-learn and easy-to-use applications is accessible from any Internet connection and provided at an affordable monthly fee. iSALUS includes unlimited technical support and customer service with all of its software subscriptions. Throughout its history, the company has served thousands of doctors and practice managers across the country. For more information, visit www.isalushealthcare.com or call 888.280.6678.

About Indiana Health Information Technology Extension Center (I-HITEC)
Indiana Health Information Technology Extension Center (I-HITEC) is a federally-designated state-chartered non-profit led by Purdue University. The organization was formed as a result of the 2009 federal Health Information Technology for Economic and Clinical Health Act and is funded through a four-year, $12 million grant. I-HITEC provides subsidized EHR adoption assistance, Meaningful Use coaching and discounted EHR products and services to Indiana’s small physician practices, public or critical access hospitals, community health centers or rural health clinics as well as other medical settings that serve the uninsured, underinsured, underserved or other at-risk populations. I-HITEC is tasked with educating and helping these entities transition from traditional, paper-based electronic health record management systems to federally-mandated electronic health record (EHR) technology. This initiative benefits Indiana through improvements to the state’s existing health information technology delivery system which will ultimately improve patient outcomes and reduce healthcare costs. To receive reimbursement from the federal stimulus program, Indiana’s healthcare providers must achieve and prove Meaningful Use of EHR software. I-HITEC plays a critical role in this process. For more information about I-HITEC, please visit www.switch.purdue.edu or call (765) 496-1911.

Filed Under: Facilities And Providers

Proteonomix, Inc. (PROT) Announces the Formation of New Subsidiary, X Gen Medical LLC, to Serve the Global Medical Market

Posted on August 6, 2010 Written by Annalyn Frame

SOURCE: Proteonomix

X Gen Medical to Function as a Joint Venture Platform for Establishing Global PRTMI Medical Facilities

MOUNTAINSIDE, NJ–(Marketwire – August 6, 2010) –  PROTEONOMIX, INC. (OTCBB: PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that it has formed a new subsidiary called X Gen Medical LLC, a Nevis Virgin Island entity. X Gen Medical has been established with the intention of conducting business in the global medical marketplace. Proteonomix plans on utilizing X Gen Medical to serve as a platform for joint ventures with medical facilities worldwide. It is anticipated that new relationships formed with X Gen Medical will create medical facilities capable of not just attracting treatments locally, but also acting as hubs for medical tourism. Medical tourism is constantly on the rise and anticipated to continue to grow substantially due to current high costs of health care for certain procedures and improvements in both technology and standards of care in many countries.

Mr. Michael Cohen, Chairman and CEO of Proteonomix, stated, “We have been in negotiations with several groups, specifically in the Middle East and Europe, to establish Proteonomix Regenerative Translational Medicine Institute (“PRTMI”) medical facilities in those regions. The negotiations have reached the level whereby the establishment of a separate subsidiary, X Gen Medical LLC., was essential in order to allow Proteonomix to properly enter these global markets with the intention of soliciting business through our proprietary PRTMI model. We anticipate closing on some of these negotiations in the near future, which we anticipate will include the necessary funding required to firmly establish X Gen Medical as a PRTMI provider.”

About Proteonomix, Inc.:

Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging skin care products. StromaCel, Inc.’s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomix’s operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. (“PRTMI”) intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies. Please also visit http://www.proteonomix.com/, http://www.proteoderm.com/, http://www.otcqb.com/ and http://www.sec.gov/.

Forward-looking statements:
Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Proteonomix, Inc. cautions that statements made in this press release constitute forward-looking statements and makes no guarantee of future performance. Actual results or developments may differ materially from projections. Forward-looking statements are based on estimates and opinions of management at the time statements are made.

Donald C. Weinberger
Adam Lowensteiner
Wolfe Axelrod Weinberger Associates, LLC
(212) 370-4500

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

Electronic Control Security, Inc. Names Robert Oliver as Vice President, Operations

Posted on August 6, 2010 Written by Annalyn Frame

SOURCE: Electronic Control Security, Inc.

CLIFTON, NJ–(Marketwire – August 6, 2010) –  Electronic Control Security, Inc. (OTCBB: EKCS) (ECSI) (www.ecsiinternational.com), a global leader in entry control and perimeter security systems, today announced the appointment of Robert Oliver as Vice President, Operations. 

Arthur Barchenko, President of ECSI, stated that “Robert will fill an important position in the Company to meet the growing demand for its products and services now and in the future. The position of Vice President, Operations will address product design and engineering, R&D, production scheduling, purchasing and inventory control in accordance with ISO 9001:2008.”

About Mr. Oliver
Robert Oliver brings decades of experience and innovation in engineering design and management to this position. He has successfully performed and managed the design, test, manufacturing, installation and maintenance of products and systems in avionics, nuclear power plant, power instruments, medical device, medical instruments, research instruments, surveillance and life safety for military, law enforcement, hospital, surgical, industrial, commercial and consumer markets domestically and internationally. He has functioned at all levels, including CEO. He has enjoyed successful deployment of security systems of his own design while working through AE firms such as Syska & Hennessey and Flack & Kurtz, among others, and for clients that include major banks and brokerage houses. He holds multiple patents in the US and elsewhere for industrial and security products and systems.”

About ECSI
ECSI is a global leader in perimeter security and a quality provider to the Department of Defense, Department of Energy, nuclear power stations, and other large commercial-industrial complexes. The Company designs, manufactures and markets physical electronic security systems for high profile, high threat environments utilizing risk assessment and analysis to determine and address the security needs of its customers. Teaming agreements with major system integrators enable ECSI to support the installation and aftermarket of its products in the U.S. and overseas. ECSI is located at 790 Bloomfield Avenue, Bldg. C-1, Clifton, NJ 07012. Tel: 973-574-8555; Fax: 973-574-8562. For more information on ECSI and its customers, please visit http://www.ecsiinternational.com.

ECSI INTERNATIONAL, INC. SAFE HARBOR STATEMENT: This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry and reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward-looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to, acceptance of our proposals, sufficiency of working capital, receipt and timing of collections from purchase orders, the availability of working capital, changes in economic conditions generally and in our industry specifically, changes in security technology, legislative or regulatory changes that affect us, changes in costs and the availability of goods and services, the introduction of competing products, changes in our operating strategy or development plans, sufficiency of cash reserves and the risks and uncertainties discussed under the heading “RISK FACTORS” in Item 1 of our Annual Report on Form 10-K for the fiscal year ended June 30, 2009 and in our other filings with the Securities and Exchange Commission. We undertake no obligation to revise or update any forward-looking statement for any reason.

FOR CONTACT:
Natalie Schneider
(973) 574-8555

Filed Under: Medical And Healthcare

Letter to Stockholders of MMRGlobal, Inc.

Posted on August 6, 2010 Written by Annalyn Frame

SOURCE: MMRGlobal, Inc.

LOS ANGELES, CA–(Marketwire – August 6, 2010) –  MMRGlobal, Inc. (OTCBB: MMRF)

Dear Stockholder:

In the entertainment industry, 2012 was the name of a major motion picture. In China, 2012 will be the Year of the Dragon. At MMRGlobal, 2012 will be the Year of the Personal Health Record (PHR). That’s when health care professionals will be required to provide Personal Health Records to patients as part of compliance with Meaningful Use.

At MMRGlobal, we’re ready for the future of health care today.

The MyMedicalRecords.com PHR already offers patented Emergency Login features, patient selected privacy controls, the ability to securely receive and send a medical record from and to any health care professional (or anyone) anywhere in the world. And it does not matter how a record is created, with paper and pen or from the most sophisticated of EMRs. Further, the MMR Stimulus Program pays physicians for simply doing what they will have to do; specifically, electronically provide patients with timely access to their personal health information. Also, because we believe in the quality, safety and security of our product, MMR carries cyber liability insurance to protect our consumer and professional users from actual loss or damage caused by an error in the Company’s PHR system.

Last week in Chicago and yesterday in Los Angeles, we met with senior executives of two hospital systems representing more than 2,000 staff physicians. Working with these hospital systems, MMR is in the process of developing programs designed to enable hospitals and larger group practices to underwrite the installation of an MMRPro system through the MMR Stimulus Program.

Also last week in meetings at Kodak headquarters in Rochester, N.Y., we began planning on numerous expanded distribution strategies and joint sales and marketing opportunities. Additionally, this month we will begin testing the next generation of an MMRPro system with new Kodak hardware, improved software and a more seamless interface that will make it faster and more efficient for doctors’ offices to digitize patient records and offer MMRPatientView.com upgrades. We anticipate distributing the new MMRPro branded system later this year at which time we will upgrade any systems in the field at no cost to our customers.

Kodak will also promote the new MMRPro system in Kodak merchandising and marketing materials designed to make it easier for resellers and distributors to sell directly. We also will participate with Kodak in an expanded tradeshow schedule, with coverage in the Kodak newsletter and inclusion on Kodak’s Partner Web site. This quarter, National Payment Providers will also begin presenting MMRPro to its database of more than 160,000 physician billing clients with delivery and installation support from Kodak starting later this year. 

I also spent last week with Chartis International executives in New York regarding sales of MyEsafeDepositBox and MyMedicalRecords domestically. Rich Teich, MMRGlobal’s Executive Vice President, also attended preliminary implementation meetings in New York this week. We anticipate announcements on these and other similar programs in the first quarter of 2011 while we continue to push forward on the international front.

Later this month, expect the launch of the new redesigned MyEsafeDepositBox, which will be the structural backbone for Chartis Esafe and numerous banking programs, including one that has been in development for more than two years.

In China, we are deploying MMRGlobal developers in Zhengzhou City to work side-by-side with the local development teams at Unis-TongHe. They will begin design plans on the two projects for presentation to China’s hospital system. These proposal efforts represent the groundwork for two health information exchange systems that can provide services to over 100 million people. 

In October, I plan on visiting our technology partner Nihilent in India as part of a strategy to present MMR to government officials, private hospital networks and local health care professionals.

In addition to our ongoing efforts to identify a strategic partner to develop the Company’s anti-CD20 monoclonal antibody assets, we continue to look at our many other biotech assets arising out of the pre-merger Favrille Specifid vaccine and, as such, we are seeking opportunities with biotech and institutional investment partners to exploit those assets.

It is an extremely busy time at MMRGlobal. I have touched on a few of the many initiatives that this company is pursuing around the world. When the recently filed S1/A goes effective, the Company will have access to up to $10 million in capital which can help accelerate our ability to execute on these business opportunities and more. It will provide resources for development, marketing and sales of our products to our consumer, health care professional, corporate and affinity clients worldwide. As the largest beneficial holder of this company, I am excited about the fact that we will have these additional resources and look forward to being in a better position to execute on our plans and grow with the global health care market.

I rarely talk about the people on the MMRGlobal team and how they are the recipe for success. It’s two o’clock AM and I am working with Bobbie after 10 years and a full day of meetings with Rich (who I have worked with for 33 years), AJ (15 years), Ingrid (20 years) and Ralph (15 years), all of whom work around the clock seven days a week. 

Then there’s our Board of Directors. They also get to be on call 24-hours a day and utilize their entire network of contacts in support of the Company. For example, Hector Barreto has supported the Company for nearly three years after leaving as the longest running Administrator of the U.S. Small Business Administration. He presided over 9/11 and Katrina and brings with him a wealth of knowledge and experience.

George Rebensdorf has worked with me on finance and regulatory affairs for more than 15 years. Bernie Stolar, who I have worked with for nearly 30 years, brings the experience of launching Sony PlayStation®, running Sega and being the Gaming Industry Evangelist for Google. Also in the 30-year category is Jack Zwissig, who is an expert in executive leadership and corporate team building. Doug Helm, who was appointed to the board of pre-merger Favrille, is a world-class expert on insurance, benefits and banking and helps lead the Company’s insurance and banking efforts. Dave Boyden, another Favrille appointee, is the biotech answer man on the scientific assets in the Company’s portfolio.

There are not many people who can write about a team that’s been together for more than 175 years.

Sincerely,

Robert H. Lorsch
Chairman, President & Chief Executive Officer

About MMRGlobal, Inc.

MMR Global, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (“MMR”), provides secure and easy-to-use online Personal Health Records (“PHRs”) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user’s account. The Company’s professional offering, MMRPro, is designed to give physicians’ offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. MMR is also an integrated service provider on Google Health. To learn more about MMR Global, Inc. and its products, visit www.mymedicalrecords.com and view the videos at www.mmrtheater.com.

Forward-Looking Statements
Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements, and some can be identified by the use of words (and their derivations) such as “need,” “possibility,” “offer,” “development,” “if,” “negotiate,” “when,” “begun,” “believe,” “achieve,” “will,” “estimate,” “expect,” “maintain,” “plan,” and “continue.” MMRGlobal, Inc. disclaims any intent or obligation to revise or update any forward-looking statements. These forward-looking statements are based on MMRGlobal, Inc.’s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The information discussed in this release is subject to various risks and uncertainties related to changes in MMRGlobal, Inc.’s business prospects, results of operations or financial condition, government regulation, and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.’s public filings with the U.S. Securities and Exchange Commission.

CONTACT:
Bobbie Volman
MMRGlobal, Inc.
(310) 476-7002, Ext. 2005
[email protected]

Michael Selsman
Public Communications Co.
(310) 553-5732
[email protected]

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

Former Illinois State Senate President Emil Jones Jr. Joins Zimek Technologies Advisory Board

Posted on August 6, 2010 Written by Annalyn Frame

SOURCE: Zimek Technologies

TAMPA, FL–(Marketwire – August 6, 2010) – Zimek Technologies (www.zimek.com), the industry leader in infection control and biohazard remediation technology, today announced The Honorable Emil Jones Jr. has joined the company’s prestigious Advisory Board. From 2003-2009, Jones served as President of the Illinois State Senate, a position that culminated more than three decades of service in the Illinois legislature. Jones has been a mentor and friend to many politicians over the years including former Illinois State Senator Barack Obama with whom Jones served. Jones is currently a Senior Counselor at Mercury Public Affairs, leading the firm’s operations based in Chicago, Ill.

“Recognized as one of the most effective political leaders in Illinois state history, Emil Jones left an unparalleled legacy of achievement, making lasting contributions throughout the state, particularly in the areas of education, health care and criminal justice,” stated Kurt Grosman, CEO and President of Zimek Technologies. “We are extremely delighted he is joining our team. His contributions will be vital as we continue to spread the word that Zimek’s sophisticated three-dimensional touch-less decontamination technology can effectively defeat and prevent the spread of deadly viruses and bacteria.”

“Zimek’s automatic rapid decontamination and disinfection technology is a powerful addition to our arsenal of weapons to fight infectious diseases and biohazard attacks,” Senator Jones said. “Zimek’s technology can meaningfully help hospitals throughout our country improve infection control quality standards and ensure they use best practices to comply with new federal provisions issued by CMS (Centers for Medicare & Medicaid Services) which encourage hospitals to disclose and, proactively, reduce their healthcare acquired infections (HAIs). HAIs will now be tied to hospital Medicare reimbursement incentives.”

Jones joins other Zimek Advisory Board members including Dr. Brad Spellberg, scientist, researcher and infectious disease specialist at the David Geffen School of Medicine at UCLA and Harbor-UCLA Medical Center; Dr. Peder Bo Nielsen, consultant in Microbiology with the United Kingdom’s North West London NHS Trust; and Dr. Lindsey Shaw, Assistant Professor of Molecular Microbiology at the University of South Florida. (see http://www.zimek.com/advisoryboard.asp).

Zimek Technologies, based in Tampa, Florida, has been developing and marketing its patented automatic Micro-Mist™ decontamination technologies for more than five years. Zimek’s industry-leading technologies are used by the U.S. Department of Homeland Security, Fire and EMS departments, healthcare facilities, public health agencies, transit systems, correctional facilities and local law enforcement agencies across America.

Contact:
Bob Mazza
310-994-4847
Email Contact

Filed Under: Medical And Healthcare

QuickMedical Launches New Video Education Webpage: Qtube

Posted on August 6, 2010 Written by Annalyn Frame

SOURCE: QuickMedical

Qtube Is the Latest Customer Education Service Offered by QuickMedical; the Free Video Presentations Provide Health Care Professionals With the Latest in Medical Supply and Equipment Updates, Product Education and Usage Information

ISSAQUAH, WA–(Marketwire – August 6, 2010) –  A new simplified and easily accessible video format where the health care professional can go to obtain the latest in medical equipment and supply information and use has finally arrived: Qtube™.

According to one research study, 50% of online retailers in the US added video in some form last year, and 31% of Fortune 500 companies have public blogs that incorporate video blogging.

“Considering that 177 million Americans watch some sort of video online each month, and they saw 4.3 billion ads in June, it’s not surprising why we would add an educational video site,” said Scott Hanna, CEO at QuickMedical®. “With nearly 150 full feature product videos and educational clinics, QuickMedical® and Qtube™ can offer our customers an easy-to-use educational site where they can learn more about the latest in product development, use and technology.”

The majority of Qtube™ product and clinic video presentations are filmed on site at QuickMedical® in their state of the art display and video production room. A number of videos are also supplied to Qtube™ by the QuickMedical® vendor/manufacturers for review and placement on the Qtube™ site.

“Our video/media team put together a dynamic website that will feature future product promotions and will help the QuickMedical® vendors create and use new video content that will promote their goods and services,” said Tim Lightell, Social Media Coordinator at QuickMedical®. “Over a two day period, this June at our open house, we filmed nearly 150 vendor/product presentations and ten educational clinics, so there is a lot of content on the Qtube™ site.”

About QuickMedical® and Qtube™:

QuickMedical® has the professional medical equipment needed by health care providers. Look for diagnostic equipment, exam tables, weighing and measuring devices, and medical basics such as stethoscopes, thermometers, and sphygmomanometers. Qtube™ Videos are supplied by our manufacturers or produced in house by our Production Team. Most videos are shot in our state of the art showrooms. Current displays include medical, surgical, and a pediatric exam rooms. Look for QuickMedical’s® new television commercial, currently airing in the Seattle market on local ABC affiliate KOMO 4.

Scott Hanna
CEO
QuickMedical
888-345-4858
Email Contact

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

Extendicare REIT Announces 2010 Second Quarter Results

Posted on August 5, 2010 Written by Annalyn Frame

EXTENDICARE REIT
Condensed Consolidated Earnings

(thousands of Canadian dollars Three months ended Six months ended
except per unit amounts) June 30 June 30
----------------------------------------------------------------------------
2010 2009 2010 2009
----------------------------------------------------------------------------
Revenue
Nursing and assisted living centers
United States 337,596 371,990 673,719 769,099
Canada 122,959 118,860 241,543 233,244
Home health - Canada 38,362 38,819 77,891 74,823
Health technology services
- United States 4,139 4,794 8,285 10,245
Outpatient therapy - United States 3,758 3,505 6,694 7,236
Other 7,557 8,631 15,073 17,593
----------------------------------------------------------------------------
514,371 546,599 1,023,205 1,112,240
Operating expenses 424,567 452,589 853,863 931,659
Administrative costs 17,505 18,917 34,484 38,836
Lease costs 2,612 3,097 5,420 6,191
----------------------------------------------------------------------------
EBITDA (1) 69,687 71,996 129,438 135,554
Depreciation and amortization 15,785 16,350 31,479 33,709
Accretion of asset retirement
obligations 393 416 793 853
Interest expense 22,800 24,479 45,994 50,316
Interest income (2,074) (709) (3,002) (1,851)
Loss (gain) on derivative financial
instruments and foreign exchange 4,505 (12,424) 1,285 (7,474)
Loss from asset impairment,
disposals and other items 2,580 594 2,580 337
----------------------------------------------------------------------------
Earnings from continuing
operations before income taxes 25,698 43,290 50,309 59,664
----------------------------------------------------------------------------
Income tax expense (recovery)
Current 11,244 14,958 22,650 25,911
Future 476 (1,206) (1,475) 397
----------------------------------------------------------------------------
11,720 13,752 21,175 26,308
----------------------------------------------------------------------------
Earnings from continuing
operations 13,978 29,538 29,134 33,356
Discontinued operations (974) 706 (564) 545
----------------------------------------------------------------------------
Net earnings 13,004 30,244 28,570 33,901
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Basic and Diluted Earnings per Unit ($)
Earnings from continuing operations 0.17 0.40 0.36 0.45
Net earnings 0.16 0.41 0.36 0.46
----------------------------------------------------------------------------
(1) Refer to discussion of non-GAAP measures.
----------------------------------------------------------------------------
Certain 2009 figures have been revised for comparative purposes.


EXTENDICARE REIT
Condensed Consolidated Balance Sheets

(thousands of Canadian dollars, unless June 30 December 31
otherwise noted) 2010 2009
----------------------------------------------------------------------------
Assets
Current assets
Cash and short-term investments 252,542 134,012
Restricted cash 19,322 22,361
Accounts receivable, less allowances 211,563 213,477
Income taxes recoverable 8,500 29,314
Future income tax assets 24,338 24,900
Other current assets 25,017 22,187
----------------------------------------------------------------------------
541,282 446,251
Property and equipment, including construction-in
-progress of $50,880 and $41,956, respectively 865,132 863,430
Goodwill and other intangible assets 194,883 191,514
Other assets 152,536 166,870
----------------------------------------------------------------------------
1,753,833 1,668,065
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Liabilities and Equity
Current liabilities
Accounts payable 37,708 38,372
Accrued liabilities 232,674 245,260
Accrual for self-insured liabilities 11,505 11,321
Current portion of long-term debt 99,013 28,538
----------------------------------------------------------------------------
380,900 323,491
Accrual for self-insured liabilities 29,126 32,562
Long-term debt 1,157,975 1,205,494
Other long-term liabilities 68,173 67,555
Future income tax liabilities 75,799 79,866
----------------------------------------------------------------------------
1,711,973 1,708,968
Unitholders' equity (deficiency) 41,860 (40,903)
----------------------------------------------------------------------------
1,753,833 1,668,065
----------------------------------------------------------------------------
----------------------------------------------------------------------------

Closing US/Cdn. dollar exchange rate 1.0646 1.0510
----------------------------------------------------------------------------


EXTENDICARE REIT
Condensed Consolidated Cash Flows

Three months ended Six months ended
(thousands of Canadian dollars) June 30 June 30
----------------------------------------------------------------------------
2010 2009 2010 2009
----------------------------------------------------------------------------
Operating Activities
Net earnings 13,004 30,244 28,570 33,901
Adjustments for:
Depreciation and amortization 15,785 16,782 31,479 34,665
Provision for self-insured
liabilities 3,942 4,988 9,433 10,313
Payments for self-insured
liabilities (8,536) (4,443) (11,659) (7,563)
Future income taxes (999) (1,204) (2,950) 391
Loss (gain) on derivative financial instruments
and foreign exchange 4,505 (12,424) 1,285 (7,474)
Loss from asset impairment,
disposals and other items 2,580 594 2,580 337
Loss (gain) from asset disposals,
impairment and other items from
discontinued operations 2,751 - 2,751 (1,426)
Other 2,596 2,866 5,229 6,205
----------------------------------------------------------------------------
35,628 37,403 66,718 69,349
----------------------------------------------------------------------------
Net change in operating assets and liabilities
Accounts receivable 10,475 9,320 2,148 24,903
Other current assets 513 608 (2,650) (6,002)
Accounts payable and
accrued liabilities (15,394) (4,555) (16,930) (12,064)
Income taxes 11,133 (8,345) 19,633 (4,843)
----------------------------------------------------------------------------
6,727 (2,972) 2,201 1,994
----------------------------------------------------------------------------
42,355 34,431 68,919 71,343
----------------------------------------------------------------------------
Investing Activities
Growth capital expenditures (6,901) (12,518) (18,517) (25,789)
Maintenance capital expenditures (5,173) (7,917) (9,759) (15,241)
Net proceeds from dispositions 5,482 - 5,482 9,995
Other assets (490) 384 (1,185) (1,710)
----------------------------------------------------------------------------
(7,082) (20,051) (23,979) (32,745)
----------------------------------------------------------------------------
Financing Activities
Issue of long-term debt 9,427 6,337 30,138 12,049
Repayment of long-term debt (6,957) (3,895) (20,365) (14,135)
Decrease (increase) in
restricted cash 3,039 (29,482) 3,039 (29,482)
Decrease in investments held
for self-insured liabilities 7,950 6,536 8,278 7,091
Purchase of securities for
cancellation - - - (6,189)
Distributions paid (15,968) (14,584) (31,086) (30,866)
Issue of units - - 82,212 -
Financing costs (476) (2,795) (740) (2,832)
Other (95) (330) (95) (1,860)
----------------------------------------------------------------------------
(3,080) (38,213) 71,381 (66,224)
----------------------------------------------------------------------------
Foreign exchange gain (loss) on cash
held in foreign currency 4,457 (1,704) 2,209 (851)
----------------------------------------------------------------------------
Increase (decrease) in cash
and cash equivalents 36,650 (25,537) 118,530 (28,477)
Cash and cash equivalents at
beginning of period 215,892 120,144 134,012 123,084
----------------------------------------------------------------------------
Cash and cash equivalents at
end of period 252,542 94,607 252,542 94,607
----------------------------------------------------------------------------
----------------------------------------------------------------------------


EXTENDICARE REIT
Financial and Operating Statistics


Three months ended Six months ended
June 30 June 30
----------------------------------------------------------------------------
(amounts in Canadian dollars, unless
otherwise noted) 2010 2009 2010 2009
----------------------------------------------------------------------------

Earnings from Continuing Operations (millions)
United States (US$) $11.8 $20.7 $22.9 $25.8
----------------------------------------------------------------------------
United States $12.1 $24.8 $23.6 $31.1
Canada 1.9 4.7 5.5 2.2
----------------------------------------------------------------------------
$14.0 $29.5 $29.1 $33.3
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Net Earnings (millions)
United States (US$) $10.8 $21.4 $22.3 $26.3
----------------------------------------------------------------------------
United States $11.2 $25.5 $23.1 $31.7
Canada 1.9 4.7 5.5 2.2
----------------------------------------------------------------------------
$13.1 $30.2 $28.6 $33.9
----------------------------------------------------------------------------
----------------------------------------------------------------------------
U.S. Skilled Nursing Center Statistics
Percent of Revenue by Payor Source (same-facility basis, excluding prior
period settlement adjustments)
Medicare (Parts A and B) 33.3% 34.1% 33.1% 34.4%
Managed Care 9.5 9.6 9.5 9.5
----------------------------------------------------------------------------
Skilled mix 42.8 43.7 42.6 43.9
Private/other 9.0 9.4 9.1 9.3
----------------------------------------------------------------------------
Quality mix 51.8 53.1 51.7 53.2
Medicaid 48.2 46.9 48.3 46.8
----------------------------------------------------------------------------
100.0 100.0 100.0 100.0
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Average Daily Census by Payor Source (same-facility basis)
Medicare 2,342 2,385 2,334 2,441
Managed Care 802 797 808 802
----------------------------------------------------------------------------
Skilled mix 3,144 3,182 3,142 3,243
Private/other 1,425 1,518 1,427 1,516
----------------------------------------------------------------------------
Quality mix 4,569 4,700 4,569 4,759
Medicaid 9,440 9,490 9,498 9,513
----------------------------------------------------------------------------
14,009 14,190 14,067 14,272
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Average Revenue per Resident Day by Payor Source (excluding prior period
settlement adjustments) (US$)
Medicare Part A only $ 457.74 $ 454.38 $ 457.40 $ 451.03
Medicare (Parts A and B) 499.77 497.31 499.87 492.07
Managed Care 415.60 417.72 412.75 415.12
Private/other 223.73 215.17 224.59 213.52
Medicaid 179.79 172.06 179.60 172.10
Weighted average 252.63 245.14 252.02 244.88
----------------------------------------------------------------------------
Average Occupancy (excluding managed centers) (same-facility basis)
U.S. skilled nursing centers 86.9% 88.3% 87.2% 88.8%
U.S. assisted living centers 78.3 82.6 78.3 82.6
Canadian centers 98.3 97.9 98.1 97.8
----------------------------------------------------------------------------
Average US/Cdn. dollar exchange rate 1.0277 1.1672 1.0338 1.2062
----------------------------------------------------------------------------


EXTENDICARE REIT
Supplemental Information - FFO and AFFO

The following table provides a reconciliation of EBITDA to Funds from
Operations (FFO), Distributable Income (DI) and Adjusted Funds from
Operations (AFFO) for the periods ended June 30, 2010 and 2009.(1)

Three months ended Six months ended
June 30 June 30
----------------------------------------------------------------------------
(thousands of Canadian dollars
unless otherwise noted) 2010 2009 2010 2009
----------------------------------------------------------------------------
EBITDA from continuing
operations 69,687 71,996 129,438 135,554
Depreciation for furniture, fixtures,
equipment and computers (5,580) (5,983) (11,033) (12,049)
Interest expense, net (20,726) (23,770) (42,992) (48,465)
----------------------------------------------------------------------------
43,381 42,243 75,413 75,040
Current income tax expense (2) (11,244) (15,448) (22,650) (26,911)
----------------------------------------------------------------------------
FFO (continuing operations) 32,137 26,795 52,763 48,129
Amortization of financing costs 2,184 2,841 4,353 5,365
Principal portion of government
capital funding payments 615 574 1,226 1,150
----------------------------------------------------------------------------
DI (continuing operations) 34,936 30,210 58,342 54,644
Additional maintenance capital
expenditures (3) 407 (1,934) 1,274 (3,192)
----------------------------------------------------------------------------
AFFO (continuing operations) 35,343 28,276 59,616 51,452
AFFO (discontinued operations)(4) 302 1,161 731 2,362
----------------------------------------------------------------------------
AFFO 35,645 29,437 60,347 53,814
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Per Basic Unit ($)
FFO (continuing operations) 0.393 0.367 0.658 0.660
AFFO (continuing operations) 0.431 0.388 0.743 0.706
AFFO 0.435 0.404 0.752 0.738
----------------------------------------------------------------------------
Per Diluted Unit ($)
FFO (continuing operations) 0.365 0.340 0.620 0.618
AFFO (continuing operations) 0.390 0.349 0.676 0.639
AFFO 0.393 0.362 0.684 0.666
----------------------------------------------------------------------------
Distributions declared 17,346 15,317 34,019 30,602
Distributions declared per unit ($) 0.2100 0.2100 0.4200 0.4200
----------------------------------------------------------------------------
Basic weighted average number of
units (thousands) 82,576 72,914 80,221 72,913
Diluted weighted average number
of units (thousands) 96,389 86,727 94,034 86,733
----------------------------------------------------------------------------

1. "EBITDA", "funds from operations", "distributable income" and "adjusted
funds from operations" are not recognized measures under GAAP and do not
have a standardized meaning prescribed by GAAP. Refer to the discussion
of non-GAAP measures.
2. Excludes current tax with respect to the loss (gain) from derivative
financial instruments, foreign exchange, asset impairment, disposals and
other items that are excluded from the computation of AFFO.
3. Represents total facility maintenance capital expenditures less
depreciation for furniture, fixtures, equipment and computers already
deducted in determining DI.
4. The impact of discontinued operations reduces FFO, DI and AFFO by the
same amount.
----------------------------------------------------------------------------

Reconciliation of Cash Provided by Three months ended Six months ended
Operating Activities to DI & AFFO June 30 June 30
----------------------------------------------------------------------------
(thousands of Canadian dollars) 2010 2009 2010 2009
----------------------------------------------------------------------------
Cash provided by operating
activities 42,355 34,431 68,919 71,343
Add (Deduct):
Net change in operating assets
and liabilities (6,727) 2,972 (2,201) (1,994)
Current tax expense on gain or loss
from derivative financial instruments,
foreign exchange, asset impairment,
disposals and other items (12) (490) (12) 1,250
Net provisions and payments for
self-insured liabilities 4,594 (545) 2,226 (2,750)
Depreciation for furniture, fixtures,
equipment and computers (5,580) (5,983) (11,033) (12,049)
Principal portion of government
capital funding payments 615 574 1,226 1,150
Other (7) 412 (52) 56
----------------------------------------------------------------------------
DI 35,238 31,371 59,073 57,006
Additional maintenance capital
expenditures 407 (1,934) 1,274 (3,192)
----------------------------------------------------------------------------
AFFO 35,645 29,437 60,347 53,814
----------------------------------------------------------------------------
----------------------------------------------------------------------------

Filed Under: Medical And Healthcare

eHealth, Inc. to Present at the Oppenheimer & Co. Inc. Annual Technology, Media & Telecommunications Conference

Posted on August 5, 2010 Written by Annalyn Frame

SOURCE: eHealth, Inc.

MOUNTAIN VIEW, CA–(Marketwire – August 5, 2010) –  eHealth, Inc. (NASDAQ: EHTH), the nation’s leading online source of health insurance for individuals, families, seniors and small businesses, today announced that its senior management will present at Oppenheimer & Co. Inc.’s Annual Technology, Media & Telecommunications Conference on Wednesday, August 11 at 8:30 a.m. ET. This event will be held at the Four Seasons Hotel in Boston, MA.

Interested investors can access the live audio webcast of each presentation at www.ehealthinsurance.com under Investor Relations. Please visit the website at least 15 minutes early to register, download, and install any necessary software. A replay of each event will be available on the company’s website shortly after the conclusion of the event and will remain available for 14 days.

About eHealth, Inc.

eHealth, Inc. (NASDAQ: EHTH), the parent company of eHealthInsurance and PlanPrescriber, is the nation’s leading online source of health insurance for individuals, families, seniors and small businesses. Through the company’s websites (http://www.eHealthInsurance.com, http://www.PlanPrescriber.com and http://eHealthMedicare.com), consumers can get quotes from leading health insurance carriers, compare plans side by side, and apply for and purchase individual and family, Medicare, small group, short-term and ancillary health insurance products. eHealthInsurance is authorized by more than 180 of the nation’s leading health insurance companies and offers thousands of health plans. eHealthInsurance is licensed to sell health insurance in all 50 states and the District of Columbia, making it an excellent model of a successful, high-functioning health insurance exchange. Through its eCommerce On-Demand solution (eOD), http://www.ehealth.com/eOD/, eHealth is also a leading provider of on-demand e-commerce software services for health plan providers. eHealthInsurance and eHealth are registered trademarks of eHealthInsurance Services, Inc. PlanPrescriber is a registered trademark of PlanPrescriber, Inc.

For more information, please contact:
Market Street Partners
Phone: (415) 445-3236
Email: [email protected]

Filed Under: Medical And Healthcare

Titan Commercial Completes Medical Office Lease

Posted on August 5, 2010 Written by Annalyn Frame

SOURCE: Titan Commercial

Health Resource Solutions Relocating to Lombard, Ill.

CHICAGO, IL–(Marketwire – August 5, 2010) –  Titan Commercial today announces the completion of a lease for 9,620 square feet located at 1806 S. Highland Ave. in Lombard, Ill. Ben Rosenfield, principal of Titan Commercial, represented the tenant Health Resource Solutions (HRS) in their relocation and helped facilitate the transaction with landlord StoneCreek Properties, represented by Cawley Chicago Commercial. HRS executed a primary term of 10 years.

“With so much vacant space in the market, we wanted to ensure that we found the best deal, location and landlord to work with. Ben Rosenfield was an excellent resource and negotiated an amazing deal on our behalf that surpassed our expectations,” said Glenn Steigbigel, President of HRS.

Health Resource Solutions is a privately owned hi-tech home health company committed to serving healthcare professionals and patients. Open 365 days a year, HRS provides quality care for patients of all ages including hi-tech geriatric and pediatric nursing, physical therapy, occupational therapy, speech therapy, telemonitoring, and all other necessary coordinated services. They are currently located at 1700 W. Hubbard Street in Chicago. For more information visit the HRS website at www.healthrs.net.

Founded in 2007, Titan Commercial is a commercial real estate brokerage firm whose mission is to improve the lives beyond those involved in the negotiation. While specializing in the acquisition, disposition and leasing of commercial real estate properties, this full service firm has completed over $200 million in transactions and is active in representing landlords, tenants, sellers, purchasers and investors nationwide. Headquartered in Illinois, Titan Commercial also has an office in Arizona. For more information, visit www.titancommercialrealestate.com or call 312.373.7100.

For More Information:
Emily VanderBeek
Marketing Director
312.373.7100

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

Number of Homeless Prisoners in Toronto Area Jails Increasing

Posted on August 5, 2010 Written by Annalyn Frame

TORONTO, ONTARIO–(Marketwire – Aug. 5, 2010) – The John Howard Society of Toronto will be releasing ‘Homeless and Jailed: Jailed and Homeless;’ a report on the increasing number of homeless individuals in Toronto area jails who are being released to areas that are unable to provide sufficient resources to aid in reintegration and deter recidivism. John Howard researchers undertook 363 interviews with incarcerated individuals in 2009 and 2010. Among this group, 22.9 percent, or roughly one of every five prisoners, was homeless when incarcerated, that is they were staying in a shelter, living on the street (in places considered unfit for human habitation), in a treatment facility, or staying at the home of a friend, paying no rent. Overall, 32.2 percent, or almost one of every three prisoners had plans upon discharge to go to a shelter, live on the street, or couch-surf at the home of a friend. Another 12 percent of these prisoners are at risk of being homeless since they do not know where they will go.

The report will be released as part of Prisoners Justice Day activities at the Holy Trinity Anglican Church (10 Trinity Square – Bay and Queen – Behind the Eaton Centre) at 12:30pm on August 10th. Prisoner’s Justice Day is an annual memorial day, dedicated to all those who have lost their lives while in custody.

Researchers Amber Kellen and Sylvia Novac will be among the presenters.

Filed Under: Medical And Healthcare

Amputee Coalition of America’s 2010 National Conference in Irvine, Calif., Inspires All Americans to Live Life Without Limitations

Posted on August 5, 2010 Written by Annalyn Frame

Email a Friend

Printer Friendly Version

Latest News Releases

Filed Under: Medical And Healthcare

Metiscan’s Outpatient Diagnostic Imaging Facility Upgrades to Web 2.0 EHR System

Posted on August 5, 2010 Written by Annalyn Frame

SOURCE: Metiscan, Inc.

Eliminates License Fee Per-Study

DALLAS, TX–(Marketwire – August 5, 2010) – Metiscan’s (PINKSHEETS: MTIZ) majority owned subsidiary Schuylkill Open MRI, Inc. (Schuylkill), which is an outpatient diagnostic imaging facility located in Pottsville, Pennsylvania providing Magnetic Resonance Imaging (MRI) services, announced today that it has upgraded its legacy electronic healthcare records (EHR) system to a new Web 2.0 based Health Language Seven (HL7) compliant EHR and practice management system.

The new EHR system enhances practice workflow, improving operational efficiencies which management believes will increase cost savings and aid the center’s staff in providing high quality patient care. The EHR system enables Schuylkill to operate as a virtually paper free and filmless practice and includes features such as patient scheduling, practice management and the electronic archiving and distribution of high-quality MRI images and patient reports. Secure access is available to radiologists and referring physicians from any location having a web-browser and a broadband connection.

Schuylkill historically licensed the use of its former EHR system. Since 2003, Schuylkill has paid a licensing fee on a per-study basis. Going forward Schuylkill has determined to purchase its own EHR system and retain FirstView EHR, Inc. (FirstView), which is also a majority owned subsidiary of Metiscan, to host and administer the system. Purchasing the new EHR system provides Schuylkill with a productivity tool that embraces today’s latest secure web technologies and eliminates the need to pay a third party a license fee on a per-study basis.

About Schuylkill Open MRI, Inc.
Schuykill Open MRI, Inc. (Schuylkill) is an outpatient diagnostic facility located in Pottsville, Pennsylvania providing Magnetic Resonance Imaging (MRI) services. Schuylkill began operations in March 2003 and currently performs MRI exams on a Siemens OPEN MRI platform and a Siemens 1.5T high-field MRI platform. Having both platforms provides Schuylkill flexibility in the studies it can conduct. Schuylkill participates in most major insurance plans and accepts Medicare, Medicaid, Worker’s Compensation claims, Personal Injury Protection (PIP) and Letters of Protection (LOPs). Schuylkill is accredited by the American College of Radiology (ACR) and is a majority owned subsidiary of Metiscan, Inc. 

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan’s actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes,” “belief,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.

Investor Relations:
Big Apple Consulting
(407) 389-5900

Click here to see all recent news from this company

Filed Under: Medical And Healthcare

  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 37
  • Next Page »

Search Our Site

Categories

  • AARP
  • AI
  • Blue Cross Blue Shield
  • Canadian Health Care System
  • CIGNA HealthCare
  • COVID-19
  • Facilities And Providers
  • FDA
  • Health Clinics
  • Healthcare Companies
  • Healthcare Plan News
  • Humana
  • MedBasics
  • Medical And Healthcare
  • Medical Malpractice
  • Medicare
  • Senior News
  • The SCOOTER Store

Pages

  • 1199 National Benefit Fund
  • A Little about Drug Preparation and Formulation Development
  • About Us
  • Achieve Your Weight Goals with Advanced Thermogenic with NMN
  • Affordable Health Insurance
  • Anavar: A Deep Dive into Athletic Benefits, Potential Side Effects, and Weight Loss Applications
    • Anavar Cycle: Benefits, Dosages, and Side Effects
      • Anavar Cycle: Benefits, Dosages, and Side Effects
    • Deca Durabolin vs Anavar: Comparing Performance Enhancers
  • B12 Elite Elixir: Vitalizing Your Health and Energy Levels
  • Benefits of Hiring a Senior Caregiving Service
  • Catastrophic Health Insurance
  • Cheap Health Insurance
  • Cheap Health Insurance Plans
  • Child Health Insurance Plans
  • Choosing a Health Insurance Plan
  • Christian Health Insurance
  • Dental Assistants and Their Future
  • Disclaimer
  • Dr. Howard Bellin: Questions about Rhinoplasty
  • Elite Health Online Dual Stack approach: Unlock your weight loss potential
  • Elite Thermogenic Formula: A Game-Changer in Weight Management and Metabolic Health
  • Finding the Right Dentist
  • Get Your Winks in Blink
  • Harnessing the Power of HGH for Vitality and Youthfulness
  • Health Insurance
  • Health Insurance Plans For Family
  • Health Sharing Plans
  • Healthcare and Hospitals: Disinfection is Key
  • High Deductible Health Plans
  • Home Care Employment in Arizona
  • Hormone Replacement Therapy
    • Harmonizing Body and Spirit: Navigating through Hormone Replacement Therapy
    • Hormone Replacement Therapy (HRT) – A Double-Edged Sword
    • Hormone Replacement Therapy (HRT): A Guide to Rebalancing Hormones
    • Hormone Replacement Therapy (HRT): Balancing the Benefits, Side Effects, and Menopausal Relief
    • Hormone Replacement Therapy: Benefits & Considerations
  • Hot ROCS: The Ultimate Solution for Enhanced Energy and Metabolism
  • How A Medical Weight Loss Plan Can Help You Get The Figure You Want
  • How Ketamine Therapy Helps Fight Depression
  • How Orthotic Insoles Improve Your Health
  • Individual Health Insurance Plans
  • John Kim Austin
  • Ketamine Uses and Benefits
  • List of Health Insurance Companies
  • Low Income Health Insurance
  • Medical Device CROs: The Role in Research and Development
  • Medical Malpractice
  • Medical Research Consultants
  • Menopause and HRT
  • Mounjaro (Tirzepatide): A Breakthrough in Diabetes and Obesity Management
  • Nicotinamide Adenine Dinucleotide – Unleashing Vital Molecule Power for Optimal health
    • Unlocking the Power of NMN in Our Advanced Thermogenic and NMN Formula
  • Oxytocin Benefits
    • Oxytocin: The Love Hormone Decoded
    • Oxytocin: The Love Hormone’s Role in Bonding and Beyond
  • Oxytocin Benefits and Hormone Therapy
  • Peptides: The Future of Health and Wellness
    • Semax Peptide – A Glimpse into Nootropic Advancements
  • Personal Lubricants for Women – Liven Up Your Life!
  • Phentermine: Benefits, Usage, and Potential Side Effects
  • Privacy Policy
  • Private Health Insurance Plans
  • Rapamycin, the anti-aging marvel and its multidimensional health benefits
    • Rapamycin: The Anti-Aging Wonder Drug
  • Rhesus Negative
  • Self Employed Health Insurance
  • Semaglutide: A Safe and Effective Alternative to Surgical Weight Loss
    • Semaglutide and its Weight Loss Benefits
    • Semaglutide: A Revolutionary Treatment Explored
    • Semaglutide: Bridging Diabetes Treatment and Weight Loss While Managing Side Effects
    • Semaglutide: Revolutionizing Weight Loss and Diabetes Management
    • Semaglutide: Transforming Weight Management and Glycemic Control
  • Short Term Health Insurance Plans
  • Student Health Insurance Plans
  • Temporary Health Insurance
  • Terms of Use
  • Testosterone Replacement Therapy Insights
    • Exploring the HCG Diet: Unveiling a Unique Pathway Towards Weight Management
    • Testosterone for Females: Balancing Health & Wellness
      • Testosterone for Females: Exploration of Hormonal Balance and Health
    • Testosterone Replacement Therapy (TRT): A Comprehensive Guide
    • Unlocking the Pivotal Role of Testosterone in Holistic Wellbeing
  • Testosterone Therapy: Weighing the Benefits, Risks, and Identifying Symptoms
    • The Vital Role of Testosterone in Health & Well-being
  • The Basic Building Blocks For a Sustained, Healthy Diet
  • The Importance of Clinical Study Software
  • The Marvels and Misgivings of Rapamycin: A Glimpse into Anti-aging and Longevity Benefits
  • The Use of Post Cycle Therapy Supplements
  • Timeless Beauty Med Spa: Elevating Skincare in Dallas, Texas
    • Achieve Your Body Goals with Emsculpt Neo: Now Available at Timeless Beauty Med Spa in Dallas, Texas
    • The Ultimate Guide to Facials: A Path to Radiant Skin
  • Travel Health Insurance
  • Ultimate Guide for Anavar Cycles
  • Understanding Metformin: Benefits and Insights
    • Metformin: A Pillar of Hope in Weight Loss Journeys
    • Metformin: The Multifaceted Medication for Modern Health Challenges
  • Understanding Nandrolone: Benefits and Uses
    • Demystifying Nandrolone: Uses, Potential Benefits, and Considerations
    • Nandrolone for Joint Pain: Efficacy, Benefits, and Considerations
    • Nandrolone: From Muscle Building to Therapeutic Uses and Side Effects
  • Unleash your Potential with Nandrolone & Deca Durabolin
  • Unleashing Glutathione’s Power: The Key to Anti-Aging and Health
  • Unlocking Testosterone’s Power: A Comprehensive Guide to Better Health
  • Winstrol – Beyond the World of Bodybuilding
    • Unlocking the Potential of Winstrol: Dosage, Benefits, and Risks

Entity Map

Disclaimer

All content on Health Plan News and information provided on this website is for informational purposes only and is not intended as a substitute for advice from your physician or other healthcare professional. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. Always consult with a healthcare professional before starting any diet, exercise, or supplementation program, before taking any medication, or if you have or suspect you might have a health problem.

Copyright © 2026 - Privacy Policy - Terms of Use - Disclaimer